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Abstract 
 
Noroviruses are enteric pathogens causing significant morbidity, mortality and economic 
losses worldwide. Secretory immunoglobulins (SIg) are a first line of mucosal defense against 
enteric pathogens. They are secreted into the intestinal lumen via the polymeric immunoglobulin 
receptor (pIgR), where they bind to antigens. However, whether natural SIg protect against 
norovirus infection remains unknown. To determine if natural SIg alter murine norovirus (MNV) 
pathogenesis, I infected pIgR knockout (KO) mice, which lack SIg in mucosal secretions. Acute 
MNV infection was significantly reduced in pIgR KO mice compared to controls, despite 
increased MNV target cells in the Peyer's patch. Natural SIg did not alter MNV binding to, or 
crossing, of the follicle-associated epithelium (FAE) into the lymphoid follicle. Instead, naïve 
pIgR KO mice have enhanced levels of the antiviral inflammatory molecules interferon gamma 
(IFN-g) and inducible nitric oxide synthase (iNOS) in the ileum compared to controls. Strikingly, 
depletion of the intestinal microbiota in pIgR KO and control mice resulted in comparable IFN-g 
and iNOS levels, as well as MNV infectious titers. IFN-g treatment of WT mice and 
neutralization of IFN-g in pIgR KO mice modulated MNV titers, implicating this antiviral 
cytokine in the phenotype. Reduced gastrointestinal infection in pIgR KO mice was also 
observed with another enteric virus, reovirus. Collectively, my findings suggest that natural SIg 
are not protective during enteric virus infection, but rather that SIg promote enteric viral 
infection through alterations in microbial immune responses.  
 1 
Chapter 1: Introduction 
 
The Immunological Threesome of Norovirus, Secretory 
Immunoglobulins, and Enteric Bacteria 
 
The text and figures presented in this chapter were recently published in Viruses, Volume 10, 
Issue 5, Pages 237-252; 2018 and Trends in Molecular Medicine, Volume 22, Issue 12, Pages 
1047-1059; 2016 
 
INTRODUCTION 
1.1  Human Norovirus is an Emerging Pathogen 
 The gastrointestinal tract is the largest mucosal surface in the body [1]. The 
gastrointestinal lumen houses a large number and variety of commensal microbes (bacteria, 
viruses, fungi, protozoa, and single-celled archaea species), collectively referred to as the 
microbiome. In addition to the commensal microbiome, pathogenic microbes can also populate 
the GI tract. One such microbe, Norovirus, is the primary cause of gastroenteritis worldwide. In 
the United States alone, human noroviruses (HNoVs) are responsible for approximately 20 
million cases of acute gastroenteritis 
 2 
annually, leading to over 70,000 hospitalizations and nearly 800 deaths [2]. HNoV infections are 
also a global problem, causing approximately US$60 billion in societal costs every year [3]. NoV 
is a genus in the Caliciviridae family. These non-enveloped, icosahedral viruses have a single-
stranded, positive-sense RNA genome, and are classified into at least six genogroups on the basis 
of their nucleotide sequence [4]. Genogroup I (GI), GII, and GIV viruses infect humans, with GII 
being the most prevalent, while GV viruses infect rodents [5]. The NoV genome contains three 
to four open reading frames (ORFs) (Figure 1.1). ORF1 encodes nonstructural proteins 
including viral protein, genome-linked (VPg) and the RNA-dependent RNA polymerase (RdRp). 
ORF2 and ORF3 encode the major and minor structural capsid proteins VP1 and VP2, 
respectively [4]. ORF4 is only found in MNVs and encodes virulence factor VF1 [6].  
 NoV transmission typically occurs by the fecal–oral route from contaminated surfaces, 
food or water, and by person-to-person spread [4], but transmission via droplets, through 
aerosolization of HNoV-containing vomitus, can also occur [7, 8]. Outbreaks occur in places 
where people gather (e.g., cruise ships, day-care centers, hospitals). They are facilitated by the 
low numbers of virions able to cause infections (i.e., low infectious dose) [9, 10], high amounts 
of viral shedding [11], high environmental stability of HNoV [12], and a relative viral resistance 
to disinfectants [13]. After an average 29-hour incubation period, HNoV infection induces 
symptoms including abdominal pain, nausea, vomiting, and diarrhea, which typically resolve 
within 1–4 days [11, 14, 15]. However, viral shedding may occur for weeks to months in 
asymptomatic healthy hosts [16], and years in immunocompromised patients [17]. The latter 
have been postulated to serve as a reservoir for future outbreaks [18]. There is no significant 
correlation between presentation of symptoms and viral burden, duration, or magnitude of NoV 
shedding, but enhanced cytokine responses correlate with HNoV symptoms and suggest immune
 3 
  
Figure 1.1: Human norovirus (HuNoV) virion and genome structure. TOP. Color coded 
ribbon structure of the murine norovirus shell (S)- and protruding (P)-domain of the virus 
capsid protein 1, dashed box indicates histo-blood group antigen binding sites. BOTTOM.  
Transmission electron micrograph of HuNoV as well as genomic organization and genome 
replication of HuNoV, a positive-sense single stranded RNA virus. (from Glass et. al. 2009) 
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mediated symptomology [11]. Complications can occur following acute infection and 
includepost-infectious irritable bowel syndrome [19, 20], life-threatening dehydration [21], 
necrotizing enterocolitis [22], and exacerbation of Crohn's disease [23].  
 Recent developments in HNoV research are overcoming the historical lack of cell culture 
and small animal models [24-26]. Nevertheless, the direct study of factors regulating HNoV 
pathogenesis in the natural host will always be limited. To counter this limitation, HNoV 
infections are studied in non-human hosts or related NoVs are investigated in their natural hosts. 
HNoVs can infect animal models, but only those with drastically reduced immune responses 
[24]. Alternatively, models relying on the natural infection of surrogate viruses can be used 
(recently reviewed [27]).  
 
1.2  Murine Norovirus Provides a Model to Study Norovirus Biology 
Murine norovirus (MNV), a natural mouse pathogen first described in 2003 [28], is 
endemic to animal facilities throughout the world [29-31]. MNV cultivation in multiple cell 
types in vitro, the ability to genetically manipulate both virus and host, and the use of acute 
[murine norovirus 1 (MNV-1)] and chronic (e.g., MNV-CR6, MNV-CR3) MNV strains add to 
the strengths of this model system [18, 27]. Together, these studies have revealed novel host 
pathways critical to the regulation of NoV infection and facilitated the exploration of NoV 
interactions with the commensal microbiome, a critically important player in mucosal infection. 
MNV provides the most widely used, readily tractable model system to explore viral factors 
regulating NoV infection.   
 5 
 The MNV system can also be used to determine host factors contributing to NoV 
infection. Cellular tropism of NoVs is determined at the level of virus entry [32]. This was 
confirmed recently following the identification of CD300LF and CD300LD as functional 
receptors for MNV [33, 34]. Expression of murine CD300LF and CD300LD in multiple non-
susceptible cells, including HeLa or HEK293T cells from nonmurine hosts, supported MNV 
infection, while infection could be reduced by competition with soluble protein or antibody [33, 
34]. Expression of the human homologue CD300F was unable to substitute for murine 
CD300LF, nor was anti-human CD300F antibody able to block infection, indicating that 
restriction of NoVs may be due to species- specific variation in these molecules, rendering them 
determinants of species specificity. CD300LF and CD300LD belong to a family of type I 
transmembrane proteins with an immunoglobulin-like extracellular domain that can bind lipids 
in the plasma membrane [35]. Both proteins are expressed in myeloid cells, which are known 
MNV target cells [36, 37]. These findings raise questions regarding their physiological role 
during MNV infection in vivo. Preincubation of MNV-1 with soluble CD300LF prevents 
mortality of Stat1- deficient mice, and Cd300lf–/– mice are resistant to viral shedding following 
oral infection with MNV.CR6 [33]. Whether MNV establishes tissue infection in Cd300lf–/– or 
cd300ld–/– mice, however, has not been reported.  
  
1.3  Reovirus is an Enteric Pathogen 
Respiratory enteric orphan virus (reovirus) is a double-stranded RNA virus in the family 
Reoviridae. Reovirus is non-enveloped, and the outer capsid and the protein core surround the 
segmented viral genome (Figure 1.2). As the name suggests, infection is initiated via the 
respiratory or gastrointestinal tract and is mostly asymptomatic, but can result in hematogenous  
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Figure 1.2: Reovirus virion and genome structure. A. Schematic of reovirus capsid and capsid 
proteins including attachment protein 1, as well as the reovirus core and segmented double-
stranded RNA genome. B. Reconstitution of Cryo-electron micrograph image of reovirus virion 
at 23 Å resolution. (from Danthi et. al 2013) 
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dissemination and myocarditis [38, 39], as well as central nervous system spread and 
hydrocephaly [40]. Reovirus attaches to epithelial cells via the attachment protein 1 interaction 
with epithelial basolateral surface protein junction adhesion molecule-A (JAM-A) [41]. 
Endocytosis of reovirus into the host cell via 1 interaction with 1 integrins stimulates 
cathepsin-mediated digestion of the outer protein shell. Reovirus uncoating results in exposure of 
viral protein 1 which mediates endosomal membrane pore formation and viral core release into 
the cytosol [42, 43]. Once in the cytosol, the transcriptionally active viral core initiates mRNA 
formation and protein synthesis [44]. In addition to epithelial cells, reovirus may also infect  
dendritic cells via JAM-A at the initial site of pathogen entry [45], which could aid in viral 
spread to the draining mesenteric lymph nodes and distal sites such as ependymal cells of the 
brain [46]. 
 
1.4  Mucosal Defenses Against Pathogens 
To combat enteric viruses and other microbes, the GI tract has evolved several host 
defense mechanisms to prevent their entry into the host. The intestinal epithelial layer that 
separates the intestinal lumen (the space where food passes through) and the interior of the body 
is only a single cell layer thick [1] (Figure 1.3). To protect itself from these microbes, the 
epithelial barrier has developed an array of defense mechanisms. Epithelial cells connected by 
tight junction complexes are a critical barrier that separate the host interior, termed lamina 
propria, from the outside world. Tight junctions, coupled with mucus production by goblet cells, 
make the intestine relatively impermeable to pathogens and antigens. The protective capacity of 
this physical barrier is further enhanced by innate and adaptive immune responses. The intestinal  
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Figure 1.3: Mucosal defense against enteric pathogens. Schematic representation of small 
intestinal tissue including intestinal vili and Peyer’s patch. The intestinal epithelial barrier is a 
single cell layer thick. Through mucosal defenses such as epithelial cell tight junctions, mucus 
production by goblet cells. Dimeric immunoglobulin A (dIgA) is secreted from the intestinal 
lamina propria into the lumen to form secretory immunoglobulin A (SIgA). SIgA binds to 
intestinal antigens and is transcytosed through highly transcytotic microfold (M cells) 
overlying the Peyer’s patch. Dendritic cells (DC) immediately underlying the M cells uptake 
SIg immune complexes and generate tolerogenic immune responses. 
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epithelium and underlying lamina propria has the largest population of T cells, B cells and 
macrophages in the body [1]. They are primarily localized in lymphoid follicles, where both 
local and systemic immune responses are initiated.  
 
1.5  Microfold (M) Cells Mediate Transcytosis of Lumenal Contents 
 Immune cell sampling of the luminal contents is necessary for generating both 
tolerogenic and inflammatory immune responses [47], a process primarily mediated by 
Microfold (M) cells [48]. M cells are specialized epithelial cells found on mucosal surfaces. M 
cells are primarily localized overlying the mucosa-associated lymphoid tissue in the follicle-
Associated Epithelium (FAE) of the small intestine, colon, tonsils, rectum, and respiratory 
system (Figure 1.4) [49, 50].  M cells function in the FAE barrier to transport luminal antigens 
across the intestinal epithelium to the antigen-presenting cells within the lymphoid follicle [48]. 
M cells are highly endocytic, and can transport macromolecules and microorganisms through the 
M cell in 10-15 minutes [48]. The M cell morphology is specifically tailored for this purpose. 
The apical surface has truncated microvilli and a reduced mucus layer, which allows luminal 
contents access to the cell surface, unlike the rest of the mucosal epithelium [51]. The basolateral 
surface of the M cell plasma membrane is invaginated, forming a "pocket" (Figure 1.4). The 
pocket increases the transcytosis rate of the M cells by minimizing the intracellular distance 
necessary to reach the basolateral surface.  
The fate of SIg-immune complexes in the lumen is not only restricted to immune 
exclusion, SIgA-immune complexes are also sampled by the host via M cells and contribute to 
maintaining homeostasis of the mucosa. ‘Retrotranscytosis’ (apical to basolateral) of SIgA  
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Figure 1.4: Norovirus and reovirus utilize microfold (M) cells to facilitate infection. Both viruses 
rely on M cells to cross the follicle associated epithelial (FAE) barrier and gain access to virus 
susceptible cells. Once across the FAE barrier, murine norovirus is free to infect immune cells (B 
cells, macrophages, T cells and dendritic cells) as well as specialized chemosensory epithelial (tuft) 
cells. Reovirus can also infect dendritic cells but primarily infects intestinal epithelial cells via 
basolatterally expressed tight junction proteins.  
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complexes across the epithelial barrier is mediated by M cells located in the mucosal-associated 
lymphoid tissue [5]. Although the identity of the receptor that mediates SIgA transcytosis on M 
cells remains unknown, the asialoglycoprotein receptor (ASGPR), a lectin-like receptor, or 
FcαRI (CD89) were ruled out as candidates [5]. Upon internalization through the M cell, 
“tolerogenic” DCs immediately underlying the M cell phagocytose SIgA-immune complexes 
[94,95]. Although binding to CD4+ T cells was noted, complexes were not internalized. Uptake 
of SIgA-immune complexes by mouse or human DCs is mediated via specific intercellular 
adhesion molecule-3 grabbing non-integrin receptor (SIGNR) 1 or the human homolog DC-
SIGN, respectively [96,97]. SIgA-immune complexes can further bind to murine intestinal DCs 
via Dectin-1, and SIGNR3 [98].  
 
1.6 Microfold (M) Cells are Necessary for Efficient Norovirus and Reovirus Infection  
 Despite their primary role as a sentinel cell involved in immune surveillance, several 
bacteria, viruses, and even prions, hijack the highly endocytic nature of M cells, and use them to 
invade the FAE [47]. In this context, M cells act as a gateway for pathogen entry, rather than a 
gatekeeper. For example, Reovirus 1 protein facilitates selective binding to M cells allowing 
for viral entry into the host interior (Figure 1.4) [52-55]. The enhanced access to the cell surface, 
easy entry into the lamina propria, and localization of potential target cells to the site of antigen 
crossing all make M cells ideal ports of pathogen entry for noroviruses. Recently, a model was 
proposed based on experimental evidence, whereby MNVs use lymphoid follicle M cells to 
overcome the epithelial barrier in order to infect B cells, macrophages, and dendritic cells (DCs) 
in the intestine, before being trafficked to local lymph nodes and distal sites by DCs [25, 55-59] 
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(Figure 1.4). B cells are also targets for HNoVs [25], but other targets exist, since humans 
deficient in B cells are still susceptible to HNoV infection [60]. Recent immunofluorescence 
analysis of small intestinal biopsy samples from HNoV-infected immunocompromised patients 
revealed the presence of HNoV infection in intestinal epithelial cells, CD68+ or DC-SIGN+ 
phagocytes (e.g., macrophages, DCs), and CD3+ cells (T cells or intraepithelial lymphocytes) 
[61]. A tropism of HNoV for enterocytes was subsequently confirmed by cultivating HNoV in 
human intestinal enteroid monolayer cultures [26]. MNV antigen is also observed in small 
intestinal epithelial cells of immunodeficient signal transducer and activator of transcription 1 
(Stat1)- and recombination activating gene (Rag1)/Stat1-deficient mice [62, 63]. Whether these 
cells are intestinal chemosensory cells (tuft cells), identified subsequently as a MNV target cell 
during persistent infection [64] remains unknown. Taken together, the data indicate that both 
MNV and HNoVs share a tropism for intestinal immune cell subsets found underlying the M 
cells within lymphoid structures of the GI tract and cells of intestinal epithelial origin. 
 
1.7  Interferon Gamma (IFN-) Inhibits Reovirus and Norovirus Infection 
Interferon-gamma (IFN-) is a cytokine with known antiviral effects. Exogenous 
treatment of cells with IFN- results in direct inhibition of reovirus binding and infection in vitro 
[65]. These findings have yet to be tested directly in vivo, however reduction of IFN- responses 
mediated by fungal Fusarium spp. T-2 mycotoxin administration resulted in enhanced reovirus 
infection, suggesting IFN- also reduces reovirus infection in vivo [66]. The role of IFN- in 
controlling norovirus infection has been studied for the past 15 years. Direct testing of IFN- 
effects on MNV-1 infection in primary and transformed cells revealed a dose-dependent decrease 
in MNV genome translation after IFN- treatment compared to untreated controls [67]. 
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Additionally, pretreatment with as little as 1 unit of IFN- was sufficient to significantly reduce 
MNV-1 infection in vitro [68]. Human norovirus consensus sequence replicon-transduced cells 
treated with IFN- exhibited reduced RNA production compared to untreated cells, suggesting 
human norovirus is also susceptible to IFN- [69]. Furthermore, activation of transcription 
factors Stat 1 and interferon regulatory factor 1 (IRF1) downstream of IFN- signaling results in 
transcription of cytokines, chemokines, and interferon-stimulated genes, which mediate anti-
MNV activity in vitro and in vivo, further implicating IFN- in noroviral immunity [70, 71]. 
However these transcription factors are also activated by type I interferons, and host IFN- serum 
cytokine responses were unchanged during d1-4 of human norovirus infection in both 
symptomatic and asymptomatic individuals as compared to their pre-challenge IFN- levels [11], 
highlighting the need for further studies into IFN- mediated nororvirus immunity. 
The above data clearly demonstrate the antiviral role of IFN- in norovirus infection, 
however the mechanism behind norovirus translation inhibition was not elucidated fully. 
Interestingly, it was determined that IFN- exerts its antiviral activity against MNV by disruption 
of the MNV replication complex. Replication complexes (RC) are intracellular host membranes 
utilized by positive-sense RNA viruses to facilitate viral replication. MNV RCs organize close to 
the nucleus and contain all MNV non-structural proteins [72]. Upon IFN- treatment, ubiquitin-
like LC3-II is ligated to the surface of the MNV RC via the E3 ligase-like autophagy complex 
Atg:12Atg5:Atg16L1 (Figure 1.5) [68, 73]. Rather than degrading the RC through the canonical 
autophagy pathway [68], LC3-II recruits granulocyte binding proteins (GBP) and immune 
related GTPases (IRGs) to the vacuolar membrane of the RC resulting in vessiculation and MNV 
RC disruption [73]. Together these data point to a model in which IFN- directly inhibits 
norovirus translation by disruption of the intracellular norovirus replication complex. 
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Figure 1.5: Model of interferon-gamma induced disruption of murine norovirus 
replication complex. Interferon-gamma induced GTPases inhibit murine norovirus 
replication complex formation within target cells resulting in inhibition of viral replication. 
Figure modeled from Biering et al. 2017. 
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1.8  Polymeric Immunoglobulin Receptor (pIgR) Structure and Expression 
In addition to cytokines, cells at mucosal surfaces also respond to secretory 
immunoglobulins (SIgs) resulting in immune-mediated pathogen regulation. SIgs elicit both 
innate and adaptive immunologic mechanisms at mucosal barriers. Polymeric immunoglobulins 
(pIg), specifically dimeric immunoglobulin A and polymeric immunoglobulin M, are made by 
plasma cells in the lamina propria underlying the epithelial barrier (Figure 1.6). They are then 
transported across the epithelial barrier with the help of the polymeric immunoglobulin receptor 
(pIgR). PIgR is a highly glycosylated [74, 75], type I transmembrane protein with a predicted 
molecular mass of ~81 kDa that is conserved among all vertebrates [76]. NoV are known to bind 
to glycosylated molecules. However, if NoV can interact with SIg carbohydrate residues, and 
what role this plays in viral sequestration, if any, within the mucus layer or NoV transcytosis 
across the barrier remains to be determined.  
 PIgR protein expression and SIg secretion are modulated by multiple factors: 
immunological, microbial, hormonal and environmental [77]. A main regulator of pIgR 
expression are immune system mediators, including IFNγ and tumor necrosis factor alpha 
(TNFα) [78]. Regulation occurs at the transcriptional level and several transcription factor 
binding sites, including nuclear factor κ-light-chain-enhancer of activated B cells (NF-kB) and 
interferon regulatory factor 1 (IRF1), are found near the 5’ end of the PIGR gene. Thus, PIGR 
gene transcription and subsequently pIgR:pIg transcytosis are upregulated following NF-κB 
activation [79]. Several immune signaling cascades, including toll-like receptor (TLR) activation 
and inflammatory cytokine signaling, converge on NF-κB and have been demonstrated to 
directly upregulate PIGR gene expression and pIgR:pIg transcytosis both in vivo [80, 81] and in  
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Figure 1.6: Transport of polymeric immunoglobulins (pIg) to the mucosal surface. (1) PIg 
(dimeric IgA (dIgA) [shown] or pentameric IgM [not shown]) made in the lamina propria bind to 
polymeric immunoglobulin receptor (pIgR). (2) Endocytosis and transcytosis of the pIg:pIgR 
complex from the basolateral to the apical side of the mucosal epithelium. (3) Intracellular 
proteolytic cleavage of pIgR creating secretory component (SC) and secretory IgA (SIgA). (4) 
Release of SC and SIgA to the mucosal surface. 
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vitro [82-84]. Thus, it is not surprising that bacteria, bacterial products, and viruses also stimulate 
pIgR in vitro [80, 85, 86]. This was also confirmed in vivo. For example, bacterial upregulation 
of pIgR expression during infection was observed during Chlamydia infection in the epithelium 
of the human reproductive tract [87]. In addition, pIgR expression increases distally throughout 
the small intestine of mice, correlating with increasing concentrations of bacteria [1, 88]. 
Hormones, such as estrogen, progesterone and androgen, are another group of host factors that 
regulates PIGR gene expression [89]. Thus, pIgR levels change during the estrous cycle, and 
pIgR is upregulated in mammary glands during lactation [90]. Furthermore, environmental 
factors such as diet [91], exercise [92], alcohol consumption [93], and likely smoking [94] also 
alter pIgR levels. For completeness, we note that recent work also indicates modulation of pIgR 
expression in cancer [95-97]. Hence, the functions of pIgR go beyond the mucosal surface. 
Nevertheless, most studies to date have focused on the critical role of pIgR as a key mucosal 
defense mediator.  
 
1.9 Polymeric Immunoglobulin Receptor (pIgR) Mediated Polymeric Immunoglobulin 
(pIg) Transport 
The extracellular portion of pIgR is composed of six domains: five immunoglobulin-like 
domains, and a sixth, which contains a highly conserved cleavage signal [78]. The intracellular 
domain contains signals for endocytosis, intracellular sorting and transcytosis. PIgR is expressed 
on the basolateral surface of ciliated epithelial cells in the mucosal epithelium [82]. Expression is 
inhibited in mucus-producing goblet cells by secretory leukocyte protease inhibitor (SLPI) via 
the NFkB pathway [98]. The main function of pIgR is to transport dimeric immunoglobulin A 
(dIgA) and polymeric immunoglobulin M (pIgM) from the lamina propria across the epithelial 
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barrier to mucosal surfaces in four main steps (Figure 1.6) [99]. 1. PIg made in the lamina 
propria binds non-covalently via the joining (J) chain to the extracellular domain 1 of pIgR, on 
the basolateral surface of the epithelial layer [100, 101]. 2. Once bound, the receptor and Ig 
undergo clathrin-mediated endocytosis, and are transcytosed through the epithelial cell to the 
mucosa [76]. 3. Upon approaching the apical surface, the pIg bound domain of the receptor 
undergoes endoproteolytic cleavage, likely by a host serine proteinase [102], and disassociates 
from the membrane-bound domain, forming secretory component (SC). SC remains associated 
with pIg, forming SIg. Unbound pIgR can also be transcytosed via the endosome to the luminal 
side of the epithelium alongside with pIg-bound pIgR. It similarly undergoes endoproteolytic 
cleavage forming SC and releasing free, unbound SC. 4. Upon release, SC and SIg diffuse into 
the mucus layer [103]. Therefore, pIgR plays a vital role during the generation of SIgs and 
becomes a part of SIgs. The clinical importance of pIgR is further underscored by the finding 
that multiple polymorphisms in the PIGR gene are linked with immunoglobulin A nephropathy 
[104]. Additionally, inflammatory diseases such as chronic obstructive pulmonary disease [105-
107], DSS-induced and T-cell-mediated colitis in mice [108, 109], as well as Crohn’s disease 
and ulcerative colitis in humans [110, 111] are highly prevalent when SIgs are absent or reduced.  
 
1.10  The Multiple Functions of Secretory Component (SC) 
 SC has multiple functions beyond facilitation of pIg transport and is critically important 
for the function of SIg [89, 112]. First, SC enhances SIg stability. While SC does not alter SIg 
antigen affinity [113, 114], SC is thought to help SIg resist proteolytic degradation by host and 
bacterial enzymes in the intestinal lumen [115, 116]. However, at least one pathogen has evolved 
ways to overcome the enhanced resistance to proteolysis. Specifically, streptococcus-specific 
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proteases degrade pIg and SIg similarly [117]. Second, SC aids in appropriately localizing SIg in 
the mucus layer. Both the SC and pIg are glycosylated via N- and O-linkages [74, 75]. These 
glycosylations aid in transcytosis and release of SIg from the epithelial cells [118]. In the distal 
gastrointestinal tract, SIg diffuses through the thick inner mucus layer and adheres to the outer 
mucus layer where intestinal bacteria are localized via binding to these carbohydrates [103]. 
Third, SC is a non-specific microbial scavenger. Both N- and O-linked glycosylations mediate 
attachment of bacteria, aiding in sequestration of bacteria in the mucus layer [119]. Thus, SC 
promotes intralumenal sequestration of bacteria. Fourth, SC can also neutralize the effect of 
toxins and prevent infections [120, 121]. Fifth, SC has homeostatic functions in the epithelium. 
For example, it can prevent activation of neutrophil effector functions [122] and neutralize IL-8 
activity [123]. Taken together, SC is a critical player in the mucosal defense arsenal. MNV has 
been shown to bind to N- and O-linked glycosylations [124], however, whether MNV binds to 
SIg and SC, remains to be determined. Additionally, the role SIg and SC may play in preventing 
MNV crossing the epithelial barrier is unknown. 
 
1.11  Lessons from Polymeric Immunoglobulin Receptor-Deficient (pIgR KO) Mice 
 PIgR is critical for the protective function of the GI tract as SIg and SC can mediate host 
protection through specific and non-specific pathogen interactions [125, 126]. In order to directly 
assess the role of pIgR/SC/SIg in mucosal homeostasis, pIgR-deficient (pIgR KO) mice were 
generated [127]. Although an initial littermate-controlled study found no alteration in bacterial 
communities in mice lacking PIgR [128], these findings have a caveat, namely, since SIg can 
pass through the digestive system [129], it may have been passed along from pIgR-sufficient 
littermate controls to pIgR KO mice obscuring any potential changes. Consistent with that, a 
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subsequent, non-littermate study using 16S rRNA analysis did reveal alterations in the feces and 
cecal microbiota in pIgR KO vs. WT B6 mice and suggested an overall 7% change in intestinal 
bacterial communities in the absence of pIgR [108]. Despite differences in microbial 
communities, colonic mucus thickness is similar in pIgR KO mice compare to controls [103]. 
Small intestinal mucus thickness has not been directly assessed; however, small intestinal 
permeability may increase with age in pIgR KO mice compared to controls [130]. These studies 
demonstrate that removal of pIgR, and therefore SIg and SC, results in alterations in the 
commensal microbiota. The role that SIg and SC play in modulating bacterial communities has 
been well demonstrated, however, the indirect role that this interaction has on enteric viral 
infections remains undetermined. 
 Although there are many similarities to WT B6 control mice, pIgR KO mice exhibit 
several key differences in addition to the aforementioned alterations in microbial communities 
(Figure 1.7, point 1). The lack of pIgR results in a lack of secretion of dIgA into the mucosa, 
and a buildup of serum IgA compared to WT mice (Figure 1.7, point 2) [127, 131]. Serum IgA 
levels may be further augmented in pIgR KO mice due to elevated numbers of B cells in the 
lamina propria compared to controls (Figure 1.7, point 3) [132]. Although no differences were 
found in CD4 T cells of the Peyer’s patch, spleen, and mesenteric lymph nodes [132], increased 
quantities of small intestinal intraepithelial lymphocytes (IELs) in pIgR KO mice have been 
reported (Figure 1.7, point 4) [133]. The latter is thought to be mediated through the enhanced 
differentiation of immature hematopoietic precursor cells, but it was not due to changes in 
proliferative capacities, ex vivo cytotoxicity, or migration into the intestinal epithelium [133]. In 
the lung, lack of SIgs through pIgR depletion (pIgR KO) results in an upregulation of pulmonary 
natural killer cells [105].  PIgR KO mice have enhanced lymphocytes compared to controls,  
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Figure 1.7: Previously reported small intestinal alterations in polymeric immunoglobulin 
receptor-deficient (pIgR KO) mice compared to C57/Bl6 (WT B6) control mice. PIgR KO mice 
exhibit: (1) alterations in intestinal microbial communities, (2) enhanced serum IgA, as well as 
enhanced numbers of intestinal (3) B cells, and (4) intraepithelial lymphocytes. 
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which could contribute to the enhanced susceptibility to inflammatory diseases seen in pIgR KO 
mice. 
 
1.12  The Multiple Functions of Secretory immunoglobulins (SIg) 
SIgs in the gastrointestinal tract are polyreactive against several bacterial species and 
primarily target intestinal commensal bacteria [134]. Most of these “natural” anti-commensal SIg 
are made through T cell-independent B cell responses [135]. Despite the lack of T cell help, 
these natural polyreactive SIgs can bind to antigens with high affinity, sometimes equivalent to 
that of T cell-dependent SIgs [136]. SIgs, of which SIgA is the most abundant, and SC mediate 
innate protection of the host via immune exclusion, neutralization, and complement activation, 
but also aid in adaptive immunity by modulating immune cell activation and function, and by 
maintaining homeostasis.  
 
1.12.1 Agglutination and Exclusion of Pathogens from Mucosal Surfaces (Immune 
Exclusion)  
 An important defense mechanism of the pIgR/SIg cycle is via agglutination of pathogens 
and subsequent exclusion from mucosal surfaces. This mechanism has been generally 
demonstrated for bacterial pathogens. One example of a bacteria modulated by SIg is 
Helicobacter pylori (H. pylori), a common pathogen that causes gastric mucosal inflammation, 
gastric cancers and peptic ulcers [137]. Indications that naturally produced SIg modulate H. 
pylori infection come from studies in pIgR KO mice [138]. These mice exhibit enhanced 
susceptibility to H. pylori infection, increased weight loss and delayed clearance compared to 
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WT C57BL/6. Furthermore, intestinal IgA concentrations inversely correlated with H. pylori 
gastric bacterial load in C57BL/6 mice. A potential mechanism for the pIgR/SIg-mediated 
control of H. pylori infection was suggested by in vitro experiments, which demonstrated that 
human colostrum SIgA inhibited bacterial binding to human stomach tissue sections in a glycan-
dependent manner [139]. The protective effect of this process in the human host is unclear since 
H. pylori-infected human gastric mucosa samples show increased levels of SC and IgA [140, 
141]. Thus, given the ability by H. pylori to establish an infection, these findings suggest that 
pre-existing SC and SIg were unable to prevent infection. However, whether SC and antigen-
specific SIg modulate the level of H. pylori infection, remains to be resolved. Immune exclusion 
and host protection mediated by pathogen-specific SIg was directly demonstrated for several 
bacterial pathogens. For example, Vibrio cholerae-specific SIgA also mediate in vivo 
agglutination and immune exclusion [142], and reduced diarrhea severity [143] and mortality 
[144] in mouse models.  
 Another example is Shigella flexneri, the causative agent of dysentery. Shigella LPS-
specific SIgA protected the intestinal epithelial barrier in rabbit ileal loops from destruction by 
virulent Shigella flexneri via trapping of the bacteria in the lumen and reducing inflammation 
[145]. Similar findings of SIgA- and SIgM-mediated bacterial agglutination, reduced 
inflammation and protection of the epithelial barrier were also made in polarized Caco-2 cell 
monolayers [146, 147]. Consistent with immune exclusion is the finding that SIgA targeting 
Chlamydia trachomatis outer membrane protein reduces infection in vitro and in vivo when 
binding the antigen extra-epithelially but not intra-epithelially [148]. SC and SIg may also bind 
pathogens during infection of naïve individuals. This scavenger function is mediated through 
glycosylation of SC and Ig molecules. For example, SC, through non-specific glycan 
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interactions, agglutinates and neutralizes Clostridium difficile toxin A [120, 149]. In addition, the 
glycan binding capabilities of enteropathogenic Escherichia coli intimin protein and type 1 
fimbral lectin mediate SIgA binding, which in turn agglutinates the bacteria and prevents 
epithelial cell damage in vitro [150].  
 Natural, non-specific SIgA also reduces Vibrio cholerae bacterial loads in vivo, and 
inhibits biofilm formation in vitro [151]. Inhibition of biofilm formation is dependent on 
mannose-containing oligosaccharides present on SC. Natural SIgA further mediates in vivo 
agglutination and intra-lumenal immune exclusion of Enterococcus faecium [152], and 
Salmonella enterica typhimurium resulting in reduced infection and inflammation of both 
pathogens [153]. Taken together, these examples indicate that SC, natural SIg, and pathogen-
specific SIg can mediate immune exclusion of mucosal pathogens and protect the host by a 
combination of innate and adaptive mechanisms. While the listed examples for immune 
exclusion are for bacterial pathogens, the same mechanism can be envisioned for other microbes. 
In fact, the microbial-scavenger function of SIgA also extends to commensal bacterial strains 
[119]. However, it is not universal for all microbes. SC did not bind to three rotavirus strains and 
in vitro infection was not impacted [149]. Thus, it will be of interest in the future to determine 
whether other viral or fungal mucosal infections can be controlled by SIg-mediated 
agglutination.  
 
1.12.2 Intracellular Neutralization and Excretion of Pathogens  
 In addition to protecting the epithelial surface via extracellular complex formation, SIgA 
may also neutralize pathogens intracellularly while being transcytosed to the apical surface. For 
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example, anti-Sendai virus or anti-influenza hemagglutinin specific IgA supplied to the 
basolateral side of polarized MCDK cells expressing pIgR was able to reduce virus infection 
from the apical side [154, 155]. Immunofluorescence analysis demonstrated intracellular co-
localization of virus and IgA, suggesting neutralization occurred inside cells. Neutralization was 
not observed for IgG, indicating a role for pIgR-mediated transcytosis of IgA. Similar findings 
were obtained with measles virus, HIV, and rotavirus [156-159]. In vitro studies of measles virus 
and HIV in epithelial monolayers further showed that antigen-specific IgA can bind virus on the 
basolateral side and mediate excretion of the immune complexes via pIgR through basolateral to 
apical transcytosis [156-160]. These data suggest the potential for IgA to trap pathogens that 
have breached the epithelial barrier and expel them from the mucosal lamina propria. Whether 
these principles extend to events in vivo has not been investigated in depth. In future, it will be of 
interest to determine if basolateral to apical excretion of SIgA-immune complexes extend to non-
viral infections, and what affect it has on within or between host spread. 
 Consistent with intracellular inactivation of virus by SIgA in vivo is a set of studies of 
rotavirus infection in mice [159, 161]. Using a murine hybridoma backpack tumor model, which 
secretes a given monoclonal antibody onto mucosal surfaces via the normal epithelial transport 
pathway, the authors showed that rotavirus-specific IgA antibodies inhibited primary infections, 
resolved chronic rotavirus infections, and protected newborn mice from diarrhea upon oral 
challenge. Inhibition of rotavirus infection in this model was not observed with non-antigen-
specific SIgA, anti-rotavirus IgG, or when antibodies were delivered directly into the intestinal 
lumen. Studies from knock-out mice suggest that non-antigen-specific, natural SIgA and J chain-
mediated transcytosis play some role during rotavirus infection, since naïve J chain-deficient 
mice lacking SIg exhibited enhanced shedding and delayed clearance of rotavirus as compared to 
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wild-type mice [162]. Taken together, these studies implicate intracellular neutralization by SIgA 
and basolateral to apical excretion of SIgA-immune complexes as a potential mechanism for 
protection of mucosal surfaces from viral infection. Whether these mechanisms apply broadly to 
all viruses infecting via mucosal surfaces or to other non-viral pathogens, or play a major role in 
vivo remains to be determined in future studies.  
 
1.12.3 SIg-Mediated Immune Modulation via Microfold Cells    
 Uptake of SIgA alone or SIgA-immune complexes by DCs is critical for dampening 
inflammatory immune responses in the intestinal mucosa and in turn mediating intestinal 
homeostasis. For example, SIgA-primed DCs exhibited reduced DC maturation and 
inflammatory cytokine secretion upon TLR stimulation compared to untreated DCs [163]. These 
DCs further induced the expansion of Foxp3+ regulatory T cells via IL-10 and TGF-β secretion 
in vitro and in vivo [163]. Furthermore, Shigella flexneri:SIgA immune complexes reduced 
expression of pro-inflammatory molecules by DCs and epithelial monolayers in vitro compared 
to the bacterium alone [146, 164]. Importantly, Peyer’s patches exposed to Shigella 
flexneri:SIgA immune complexes showed reduced induction of inflammatory mediators and 
tissue damage as compared to bacteria alone [145]. The anti-inflammatory effect appears to be 
specific to SIgA, as serum IgA-immune complexes enhance production of pro-inflammatory 
cytokines by monocytes and macrophages [165]. These data highlight the important role of SIgA 
in directly downregulating immune responses in the intestinal mucosa, thereby contributing to 
mucosal homeostasis.  
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1.12.4 SIg-Induced Complement Activation and Immune Pathology  
 Once the pathogen has crossed the epithelial barrier, complement activation and 
antibody-mediated phagocytosis are important host effector functions [166]. Therefore, SIgs may 
also protect the mucosal surface SIgA by these effector mechanisms. Consistent with such 
effector functions, SIgA agglutinates Streptococcus pneumoniae and opsonizes the bacteria in a 
complement-dependent manner [117]. However, the importance of these host defenses during 
bacterial pathogenesis remain to be determined. Similarly, the ability of human SIgM to activate 
human complement was recently demonstrated [167]. It will now be interesting to see whether 
SIgM mediates efficient opsonophagocytosis of pathogens at mucosal surfaces and any 
inflammatory consequences that might result from complement activation. Thus, the possibility 
exists that SIg is not always protective but may instead contribute to disease under some 
circumstances. One example for the detrimental effects of SIgs comes from herpes simplex virus 
2 (HSV-2), the common cause of genital herpes. J chain-deficient mice intravaginally infected 
with HSV-2 exhibited reduced vaginal symptoms (erythema, swelling, and ulceration) and hind 
limb paralysis, despite equivalent viral titers in the vaginal fluid compared to controls [168]. 
Additionally, treatment of intestinal organoid and immune cell co-cultures with uncomplexed 
SIgA triggers enhanced production of the pro-inflammatory cytokines interleukin 8 and tumor 
necrosis factor alpha, and increased mucus production and pIgR expression [169]. These 
responses were attenuated when SIgA was complexed with a commensal Escherichia coli, 
suggesting SIg elicits distinct immune responses upon antigen binding. These data highlight that 
depending on the circumstances, SIg can be protective for the host via induction of immune 
tolerance or immune exclusion, or it can also have negative consequences for the host through 
activation of complement or immune-mediated histopathology.  
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1.13 Subversion of the pIgR/SIg System by Pathogens  
 Given the critical defensive role of pIgR and SIg, some pathogens have evolved strategies 
to hijack this system to enhance their own infection. Chiefly among those is Streptococcus 
pneumoniae (S. pneumoniae)—a gram-positive bacterium and a leading cause of invasive 
disease in children and adults worldwide [170]. S. pneumoniae binds to human SC [171]. 
Binding to pIgR aids in attachment and infection of human nasopharyngeal epithelial cells in 
vitro by reverse transcytosis [172]. Sensing of the infection by the host cells mobilizes 
intracellular calcium stores and reduces S. pneumoniae internalization in vitro [173]. Lack of SC 
in both pIgR KO and p62yesKO mice resulted in reduced S. pneumoniae lung infection [172]. 
Thus, high expression of pIgR in the nasopharynx is thought to promote S. pneumoniae 
colonization of the upper respiratory tract [106]. Antigen-specific SIgA is further important in 
protecting the host from nasal colonization [174]. It is known that NoV can bind to carbohydrate 
residues similar to those on pIgR, but the role pIgR plays in NoV epithelial cell infection is 
unknown. 
 Consistent with the immunologic upregulation of pIgR, overexpression of pIgR was 
observed in a mouse model of chronically inflamed lungs (i.e., SPC-HAxTCR-HA mice) [175]. 
However, chronic inflammation resulted in resistance rather than susceptibility to infection by S. 
pneumonia, likely because of increased levels of airway mucosal SIgA or SIgM. PIgR may also 
aid in S. pneumoniae meningitis, as pIgR was found to colocalize with S. pneumoniae in brain 
samples from human patients who had succumbed to meningitis, and anti-pIgR antibodies 
administered intravenously prior to infection prevented pneumococcal entry into the brain and 
subsequent meningitis in mice [176]. Thus, the capability of S. pneumonia to bind pIgR is a 
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virulence determinant. Another pathogen that binds to SC is Candida albicans—an opportunistic 
pathogen and important cause of vaginal infections [177]. Earlier work showed that C. albicans 
attachment to epithelial cells in vitro is aided by a component of human saliva [178]. Recently, 
C. albicans cells were demonstrated to specifically bind to free SC in saliva, and this interaction 
aids in epithelial cell attachment in vitro [179]. However, whether SC also aids in C. albicans 
internalization and/or infection remains to be determined.  
 Epstein–Barr virus (EBV)—the causative agent of infectious mononucleosis [180]—
successfully hijacks the immune defense function of SIgA to expand its cell tropism. 
Specifically, EBV:EBV-specific SIgA immune complexes bind to pIgR on non-susceptible 
epithelial cells and are internalized to initiate infections in vitro [181, 182]. Subsequent in vivo 
experiments showed that pIgR-mediated the transcytosis of EBV immune complexes via 
hepatocytes and aided in dissemination [183]. The ability of EBV immune complexes to be 
translocated from the basal to the apical side without infection was confirmed in vitro in 
polarized pIgR-expressing MDCK cells. In contrast, infection was observed when the cells 
remained unpolarized, suggesting loss of polarization predisposes epithelial cells to EBV 
infection following reactivation from latency in the presence of anti-EBV-specific SIgA. In 
contrast to hijacking the pIgR/SIg system for their own benefit, some pathogens appear to evade 
the anti-microbial function by suppressing pIgR. For example, enterotoxigenic E. coli suppresses 
pIgR mRNA expression in vivo [184]. Similarly, simian immunodeficiency virus (SIV) and 
chimeric simian/human immunodeficiency virus (S/HIV) was able to downregulate pIgR mRNA 
expression in the gastrointestinal and respiratory mucosa of infected rhesus macaques [185, 186], 
suggesting HIV may also use pIgR downregulation as an immune evasion tactic. Taken together, 
these examples suggest that some bacterial, viral and fungal pathogens can subvert the protective 
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functions of pIgR and SIg to facilitate their own infections or inhibit their defense response. It 
will be interesting to see in the future whether additional mucosal pathogens have evolved 
similar or different pIgR/SIg subversion or evasion mechanisms.  
 
 1.14 Conclusions  
 Taken together, overwhelming evidence supports that SC, natural SIg, and pathogen-
specific SIg binding is an essential host defense mechanism. SIgs bind pathogens either 
specifically through their antigen-binding domain, or non-specifically via carbohydrate residues 
resulting in pathogen agglutination and immune-mediated exclusion of pathogens from mucosal 
surfaces. As SIg are being formed, they mediate intracellular neutralization and excretion of 
pathogens. Despite potential NoV binding sites on pIgR, SC and SIg nothing is known regarding 
their role in innate enteric defense against NoV. Specifically, it is known that NoV can bind to 
carbohydrate residues similar to those on pIgR [74, 187, 188], but the role pIgR plays in NoV 
epithelial barrier crossing is unknown. Intestinal microbiota also express carbohydrate residues 
and HNoV binding to certain intestinal bacteria enhances NoV infection [25, 189]. The 
microbiome is a critical regulator of pIgR and SIg expression, which in turn then modulates the 
microbiome. Whether NoV infection is regulated directly by natural non-specific SIg or SC 
through immune exclusion or neutralization, or indirectly through modulation of intestinal 
microbial communities remains unexplored. These findings highlight the need to further study 
complex, trans-kingdom interactions and their effects on the host.  
 The cellular and tissue tropism is a critical determinant of pathogenesis and an active area 
of investigation in the NoV field [190]. In addition to potential modulation of NoV infection by 
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innate SIg functions, adaptive immune functions may also control NoV infection. SC and natural 
SIg are also capable of manipulating host immunity mucosal tolerance via modulation of 
cytokines and regulatory immune cell development. Immune cell subsets of the gastrointestinal 
tract are in highest abundance in the lymphoid tissue, and most reside immediately underlying 
the M cells allowing them direct access to newly transcytosed antigens. M cells retrotranscytose 
SIg into the lymphoid follicles allowing direct sampling of SIg-immune complexes by intestinal 
antigen-presenting cells. The antigen-sensitized cells stimulate local immune responses in the 
lymphoid follicle and can migrate to the lymph nodes to generate systemic responses [191]. The 
role that SIg and SC play in modulating bacterial communities has been well demonstrated, 
however, the indirect role that this interaction has on enteric viral infections remains unexplored. 
 Despite several mechanisms of SIg-mediated mucosal protection, pathogens are still able 
to modulate SIg and utilize it to facilitate infection. Studies that address SIg and SC subversion 
or evasion mechanisms among mucosal pathogens are less explored. It would be interesting to 
know if different kingdoms have shared or specific evasion strategies. Addressing these and 
other future studies on how pathogens modulate and subvert SC and the SIg cycle will aid in 
further dissecting the complex roles of SIg in mucosal defense and infection. Future studies of 
the multifaceted regulation of NoV infection using existing and newly developed models will 
undoubtedly yield new scientific insights that may ultimately reduce the global burden of 
disease.  
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Chapter 2: Results 
 
Natural Secretory Immunoglobulins Promote Enteric 
Viral Infection 
 
Some text and figures presented in this chapter were published as a “Spotlight” article of 
significant interest in The Journal of Virology 92:e00826-18. https://doi.org/10.1128/JVI.00826-
18 
 
2.1 Introduction 
The mucosal surface of the gastrointestinal tract is a potential entry point for many 
pathogens. To protect itself from pathogen attack, the host has evolved multiple mechanisms, 
including the secretion of immunoglobulins (i.e., secretory immunoglobulins (SIg). SIg 
neutralize microorganisms in the intestinal lumen and reduce the immunogenicity of remaining 
bacteria [1]. Intestinal epithelial cells transcytose polymeric IgA (pIgA) and pIgM from the 
lamina propria via the basolaterally expressed polymeric immunoglobulin receptor (pIgR). Once 
the pIgR:pIgA/M complex reaches the intestinal lumen, the receptor is cleaved, and SIgA and 
SIgM are released [1]. Pathogens that have crossed the epithelial barrier and those present in 
intestinal 
 44 
epithelial cells can also be expelled by this transcytotic process [2]. Highlighting the 
defense function of this process are studies demonstrating that deletion of pIgR results in 
increased pathogen loads for Helicobacter pylori [3], Giardia muris [4], Salmonella spp. [5] and 
Clostridium difficile [6].  
SIgA are the predominant species of immunoglobulins in the intestine [7]. In addition to 
their host defense function, they also play an immunomodulatory role [7]. The follicle- 
associated epithelium (FAE) of Peyer’s patches (PP) and other mucosal-associated lymphoid 
follicles contain transcytotic microfold (M) cells. SIgA aid in the luminal sampling and the 
initiation of mucosal immune responses. Selective adherence of luminal SIgA to the M cell 
surface triggers uptake of SIgA immune complexes into the PP [8], resulting in ‘retrograde’ 
SIgA sampling by dendritic cells (DC) [9], non-inflammatory activation of DC, and induction of 
regulatory T cells [7]. The SIgA-induced anti-pathogenic immune responses also, non-
specifically, reduce the inflammatory potential of macrophages via upregulation of inhibitory 
receptors [10].  
Noroviruses are the leading cause of acute gastroenteritis worldwide [11, 12]. Targeting 
host entry and infection initiation may provide an avenue for intervention, as they are 
instrumental in determining host range, initiation of immune responses, and pathogenesis. 
However, limited information is available about factors that promote or inhibit norovirus 
infection. To gain a better understanding of the early events during norovirus infection in a 
natural host, I took advantage of murine norovirus (MNV), a well-established and highly 
tractable animal model for studying norovirus biology [13-15]. The first MNV strain to be 
discovered, MNV-1 [16], initiates infection in the ileum [17] but is cleared within days [18]. 
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Infection is primarily detected in antigen-presenting cells (APCs) (i.e. dendritic cells [DCs] and 
macrophages) and lymphocytes (T and B cells) [19-21]. To reach these target cells, MNV-1 
hijacks M cells for targeted delivery [17, 22, 23]. Reovirus is another enteric virus, which uses M 
cells during infection of the intestine [17, 24], and both viruses require enteric bacteria for 
optimal pathogenesis [25-27].  
No information is available about the role of natural SIg during enteric virus infection. 
Therefore, I infected mice deficient in pIgR (pIgR KO) with MNV and reovirus. Surprisingly, 
and contrary to previous studies [4, 5, 28], MNV-1 and reovirus T1L loads were reduced in the 
gastrointestinal tract of pIgR KO mice compared to C57BL/6 controls (WT B6). This was 
despite enhanced numbers of DCs, macrophages, and B cells, MNV target cells, in the PP of 
pIgR KO mice. However, compared to WT B6 mice, naive pIgR KO mice had enhanced baseline 
levels of inducible nitric oxide synthase (iNOS) and interferon gamma (IFN-ɣ), a cytokine with 
known anti-MNV and anti-reovirus activities [29-33]. Neutralization of IFN-ɣ in pIgR KO mice 
or addition of IFN-ɣ to WT B6 mice resulted in modulated MNV-1 viral loads. Taken together, 
our findings support a model whereby SIg downmodulates antiviral cytokine levels, thereby 
promoting enteric viral infection. 
 
2.2  Results 
2.2A Acute Norovirus Infection is Reduced in Polymeric Immunoglobulin Receptor KO 
Mice  
To investigate the role of SIg during norovirus infection, I analyzed MNV-1 infection in 
mice lacking the polymeric Ig receptor (pIgR) [34]. Since assessment of viral replication in the 
intestine is confounded by the lingering presence of the inoculum, neutral red, a light-sensitive 
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dye, was incorporated into MNV-1 virions (MNV-1-NR). Exposure to white light inactivates 
MNV-1-NR virions in a time-dependent manner resulting in a 3-log reduction in viral titers 
versus virus exposed to red light only (Figure 2.1A). A preliminary experiment (n=1) suggested 
maximum inactivation occurs between 20-30 minutes of white light exposure, and longer 
exposure to white light did not inactivate the virus further (Figure 2.1B). In vivo, newly 
replicated MNV-1 particles in the animal will be devoid of NR providing a means to differentiate 
between input (i.e., light-sensitive) and replicated (i.e., light-tolerant) virus [35].  
To determine the kinetics of acute MNV-1 infection in WT B6 mice, a previous graduate 
student, Dr. Juliana Bragazzi-Cunha, first performed a time-course of MNV-1-NR infection via 
oral gavage (o.g.). Viral loads were measured at 9, 12, 18, and 24 Hours post-infection (hpi). 
These results suggest that the first round of MNV-1 replication occurs within 9 hpi in the distal 
small intestine and mesenteric lymph node (MLN) after oral infection of WT B6 mice (data not 
shown). Next, I compared MNV-1 infection in naïve pIgR KO and WT B6 mice. In collaboration 
with Sadeesh Ramakrishnan from the Shah laboratory at University of Michigan, we first 
confirmed that fecal levels of IgA were undetectable in pIgR KO mice, while serum IgA levels 
were significantly increased compared to WT B6 mice (data not shown) in accordance with the 
literature [36, 37]. Then, I measured MNV-1-NR viral loads in the intestinal tract and draining 
lymph nodes of pIgR KO and WT B6 mice at 9, 18 and 48 hpi. 
 Consistent with previous results, infection was detected in the MLN at 18 hpi and viral 
loads were maintained at 48 hpi in WT B6 mice. However, infection in pIgR KO mice was 
delayed and did not reach WT B6 levels until 48 hpi (Figure 2.2A). Consistent virus replication 
was not detected in the duodenum at any time point tested for either mouse strain (Figure 2.2B). 
Jejunal MNV-1 replication peaked at 18 hpi in WT B6 mice, while no consistent replication was  
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B. 
A. 
Figure 2.1: Kinetics of MNV-1-neutral red light sensitivity  
A-B. Neutral red labeled MNV-1 was protected from, or exposed to, white light for the indicated 
minutes. Viral titers were assessed via plaque assay performed in a darkened room using a red 
photolight. A. Data are from three independent experiments. Error bars are standard error of the 
mean (SEM). B. Data are from one experiment. 
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  Figure 2.2: Acute MNV-1 infection is reduced in pIgR KO mice  
A-G. Mice were infected by oral gavage with 3.8x10
5
 PFU/animal neutral red labeled MNV-1, 
and tissues were harvested at 9, 18 and 48 hpi in a darkened room using a red photolight. The 
tissue homogenates were serially diluted and exposed to white light for 30 min. Replicated viral 
titers in the indicated tissue of WT B6 and pIgR KO mice were assessed via plaque assay. The 
sensitivity threshold for each graph is indicated by the dashed line and is as follows (log PFU/g 
tissue): A. 2.17 B. 2.21 C. 2.3 D. 2.37 E. 2.27 F. 2.22 G. 2.37. Data are pooled from at least 
two independent experiments and each symbol is a data point from an individual animal. Error 
bars are standard error of the mean (SEM). Data were analyzed using Mann Whitney U test. *= 
P<0.05. **= P<0.01. ns = not statistically significant. 
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observed in pIgR KO mice after 9 hpi (Figure 2.2C). Surprisingly, MNV-1 replication was 
significantly reduced in the ileum of pIgR KO mice compared to WT B6 at all time points tested 
(Figure 2.2D). Cecal MNV-1 replication increased throughout the time course in pIgR KO mice, 
but was not significantly different from WT B6 mice (Figure 2.2E). In contrast, colon titers were 
significantly reduced in pIgR KO mice at 18 and 48 hpi compared to WT B6 mice (Figure 
2.2F). Fecal shedding was only detectable in WT B6 mice at 18 hpi and below the limit of 
detection in pIgR KO mice (Figure 2.2G). Taken together, these data demonstrate that pIgR KO 
mice have reduced viral loads, suggesting that natural, non-MNV specific, SIg are not protective, 
but instead enhance acute norovirus infection in vivo. 
To determine if another strain of MNV will recapitulate the reduced MNV-1 viral loads 
in pIgR KO mice compared to controls, I used MNV-CR3 complexed with Neutral Red (MNV-
CR3-NR), a strain of MNV with different infection kinetics and pathogenesis features than 
MNV-1. MNV-CR3 replicates slower and establishes a persistent infection in vivo [17]. 
Experiments to determine the kinetics of oral MNV-CR3-NR infection in WT B6 mice were 
performed in the lab previously by Dr. Juliana Bragazzi-Cunha. Using MNV-CR3-NR she 
determined that replicated MNV-CR3 was first detected in the cecum at 12 hpi (data not shown). 
By 24 hpi replicated virus was also detectable in the ileum and ascending colon in the majority 
of mice and had started spreading to the jejunum in some mice (data not shown). The spleen, 
MLN, stomach, duodenum, and descending colon failed to replicate MNV-CR3 within 24 hpi 
(data not shown). Using 12 hpi time point for MNV-CR3-NR, I sought to determine if reduced 
MNV infection in pIgR KO mice is MNV strain-dependent. Similar to the kinetics experiments 
performed previously, I detected very little MNV-CR3 replication in the small intestine and feces 
(Figure 2.3A-C, 2.3F). Robust viral replication was detected in the cecum, and infection had  
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C D
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A
Figure 2.3: PIgR is dispensable for acute MNV-CR3 infection  
A-G. Mice were infected by oral gavage with 2.6x10
5
 PFU/animal neutral red labeled MNV-CR3, 
and tissues were harvested at 24 hpi in a darkened room using a red photolight. The tissue 
homogenates were serially diluted and exposed to white light for 30 min. Replicated viral titers in 
the indicated tissue of WT B6 and pIgR KO mice were assessed via plaque assay. The sensitivity 
threshold for each graph is indicated by the dashed line and is as follows (log PFU/g tissue): A. 2.7 
B. 2.7 C. 2.7 D. 2.82 E. 2.82 F. 2.82. Data are pooled from two independent experiments and each 
symbol is a data point from an individual animal. Error bars are standard error of the mean (SEM). 
Data were analyzed using Mann Whitney U test. ns = not statistically significant. 
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spread to the colon in some animals (Figure 2.3D, 2.3E). Interestingly however, no differences 
in viral loads were observed between mouse strains throughout the GI tract during MNV-CR3 
infection, suggesting that reduced MNV infection in pIgR KO mice is strain-dependent. 
 
2.2B Acute Reovirus Infection is Reduced in Polymeric Immunoglobulin Receptor KO 
Mice  
To determine if the observed pIgR KO phenotype extended to another virus, pIgR KO 
and WT B6 mice were infected with reovirus T1L and tissues were harvested at 24 hpi. Our 
collaborator Dr. Bernardo Mainou (Emory University) measured reoviral loads in the intestinal 
tract and mesenteric lymph nodes. Reovirus T1L infection was similar in the mesenteric lymph 
nodes, duodenum, jejunum, and feces of both mouse strains (Figures 2.4A-C, 2.4G). However, 
pIgR KO mice had significantly reduced infection in the ileum, cecum, and ascending colon 
compared to controls (Figure 2.4D-F). Taken together, these data demonstrate that similar to 
MNV-1, natural SIg are not protective during reovirus infection. In summary, our findings show 
that pIgR and SIg do not directly inhibit enteric viral infection, instead SIg promote enteric viral 
infection. To investigate the mechanism behind this enhancement in viral infection we chose to 
use MNV-1 as the MNV-1 infection model is established in the Wobus lab. 
 
2.2C Natural Secretory Immunoglobulins Do Not Facilitate Norovirus Access to Peyer's 
Patches  
To determine if the effect of reduced MNV-1 infection following oral infection seen in 
pIgR KO mice is specific to the intestinal mucosa, I infected pIgR KO and control mice 
intraperitoneally with MNV-1-NR and assessed viral replication at 9 hpi. These data show no  
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Figure 2.4: Acute reovirus infection is reduced in 
pIgR KO mice  
A-G. Mice were infected by oral gavage with 2x10
6
 
PFU/animal of reovirus T1L, and tissues were harvested 
at 24 hpi. Viral titers in the indicated tissue of WT B6 
and pIgR
 
KO mice were assessed via plaque assay. Data 
are pooled from two independent experiments and each 
symbol is a data point from an individual animal. Error 
bars are standard error of the mean (SEM). Data were 
analyzed using Mann Whitney U test. *= P<0.05. **= 
P<0.01. ns = not statistically significant 
A. B. 
C. D. 
E. F. 
G. 
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significant differences in viral load in the small intestine at 9 hpi (Fig 2.5), suggesting the defect 
in oral MNV-1 infection of pIgR KO mice may be localized to the epithelial barrier. This defect 
in oral infection is consistent with the role of SIg at mucosal surfaces and could be a result of 
reduced epithelial barrier crossing, or localized mis regulation of immunity within the PP in the 
absence of tolerizing SIg. To determine if reduced access to the distal small intestine was the 
cause of reduced MNV-1 replication in pIgR KO mice, I determined intestinal peristalsis rates in 
pIgR KO and WT B6 mice. Using Evans Blue dye as a marker of intestinal transit, I found that 
small intestinal transit was equivalent in pIgR KO mice compared to controls (Figure 2.6A). 
These data suggest that access to the distal small intestine cannot account for the reduced MNV-
1 replication seen in pIgR KO mice. 
M cells are necessary for efficient MNV infection [17, 22], so I next investigated M cell-
associated gene expression. Host mRNA was isolated from PP in the ileum of naïve pIgR KO 
and WT B6 mice and analyzed for transcript levels of SpiB (a transcription factor required 
during M cell development) and GP2 (a marker of mature M cells) [38]. No differences in 
expression levels were observed for both genes between both groups (Figure 2.6B). These data 
suggest that the virus encounters similar levels of functional M cells during infection of both 
mouse strains, suggesting the reduced MNV-1 infection in pIgR KO mice is not due to reduced 
viral transcytosis. It further suggests that the lack of immune complex sensing by the intestinal 
immune cells does not significantly affect M cell gene transcription. 
           SIg are taken up by M cells and sampled by an underlying network of MNV-susceptible 
APCs [7]. To determine whether natural SIg aid in viral targeting to and transcytosis across the 
FAE, a previous graduate student Dr. Mariam Gonzalez-Hernandez, first determined whether 
MNV-1 was capable of interacting with non-NoV specific, recombinant sIgA. These data  
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Figure 2.5: PIgR is dispensable for intraperitoneal MNV-1 infection  
A-C. Mice were infected intraperitoneally with 3.8x10
5
 PFU/animal neutral red labeled MNV-
1, and tissues were harvested at 9 hpi in a darkened room using a red photolight. The tissue 
homogenates were serially diluted and exposed to white light for 30 min. Replicated viral titers 
in the indicated tissue of WT B6 and pIgR KO mice were assessed via plaque assay. The 
sensitivity threshold for each graph is indicated by the dashed line and is as follows (log PFU/g 
tissue): A. 2.00 B. 2.16 C. 2.42. Data are pooled from three independent experiments and each 
symbol is a data point from an individual animal. Error bars are standard error of the mean 
(SEM). Data were analyzed using Mann Whitney U test. ns = not statistically significant. 
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B. 
C. 
Figure 2.6: Natural SIgA biding to MNV-1 fails to neutralize infection in vitro 
A. Evans blue dye was administered to fasting pIgR KO and B6 mice. After 15 minutes the stomach 
and small intestine were harvested. The small intestine was divided into fifths and transit of the dye 
was measured by absorbance at 562 nm. Data are pooled from two independent experiments and each 
symbol is a data point from an individual animal. Data was analyzed using 2-way ANOVA. B. 
Transcript levels of M cell-related genes, Spi-B and GP2, from WT B6 and pIgR KO
 
Peyer's patches 
over GAPDH transcript levels are shown as 2^-(ΔΔCT) in reference to WT B6. ΔCT values were 
analyzed for statistical significance. Each symbol is a data point from an individual animal. Data were 
analyzed using Mann Whitney U test. ns = not statistically significant. C. MNV-1 (2.8x10
7
 PFU) was 
pre-incubated with 0.25 mg/ml recombinant SIgA or bovine serum albumin for 1 hour in 37°C water 
bath, and neutralization was assessed via plaque assay. Error bars represent standard error of the mean 
(SEM) and each data pint represents an individual animal. Data were analyzed using Mann Whitney U 
test. ns = not statistically significant. 
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demonstrated the MNV interaction with natural SIgA is restricted to the P domain (data not 
shown), which also interacts with host cell receptors and contains neutralizing antibody epitopes 
[39]. Furthermore, SIgA did not affect viral infection in vitro, since no difference was observed 
in MNV-1 titers by plaque assay when complexed with recombinant, non-antigen specific SIgA 
compared to protein control (Figure 2.6C). 
Since MNV-1 was able to bind to recombinant, non-MNV specific SIgA, I next 
performed ligated ileal loop assays to determine whether MNV-1 uptake was altered by the 
presence or absence of non-specific SIg. A potential caveat in assessing MNV-1 FAE binding 
and crossing, is that MNV binds mucus [40] which could potentially trap the virus confounding 
our results of FAE binding. Dithiothreitol (DTT) has been shown to degrade mucus and should 
remove any mucin bound MNV from the PP [41]. Nothing is known regarding the effect of DTT 
on MNV cell surface binding, so to assure that DTT treatment would not remove virions bound 
to the cell surface a binding assay was performed in the macrophage like cell line, RAW26.7 
cells. MNV-1 was allowed to bind to RAW26.7 cells for one hour on ice. After washing 
unbound virus, cells were treated with DTT and bound viral genome copies were assessed via 
RT-qPCR. I found no differences in MNV-1 binding of DTT-treated cells as compared to 
untreated control cells (Figure 2.7A). These data suggest that DTT will not remove virus bound 
to the PP FAE.  
To investigate potential differences in MNV PP access, ileal PP of naïve pIgR KO and 
WT B6 mice were ligated to create a ~2 cm closed loop, and virus was injected as the loop was 
sealed (Diagram Figure 2.7B). After 25 minutes, whole PP were excised, and mucus-bound 
virions were removed prior to measuring viral genome titers by qRT-PCR. No difference was 
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observed in viral genome copies between the two groups (Figure 2.7C) suggesting similar 
amounts of virions bound and/or entered the PP in either mouse strain.  
Since MNV-1 primarily infects immune cells [19], I further assessed the amount of 
virions that reach PP lamina propria. To determine if I could distinguish between virus bound to 
the FAE, and virus that had crossed the barrier into the PP lamina propria, I digested the PP FAE 
with 2 mM EDTA. This resulted in a ~5 fold reduction in epithelial cells (EpCam+) as measured 
by flow cytometry (data not shown). Although these results are preliminary (n=1), they suggest 
that separation of the FAE from the lamina propria is possible. Ileal loops were performed, and 
after 25 or 40 minutes of virus incubation the PP FAE was digested away from the PP lamina 
propria with 5 mM EDTA, and viral genome levels were determined by RT-qPCR. There were 
no significant differences in the amount of virus that associated with the PP FAE between mouse 
strains at either timepoint (Figure 2.7D). More uniform FAE binding was seen after 40 minutes, 
however overall virus attachment was not enhanced above 25 minutes of virus incubation 
(Figure 2.7D). There was also no difference in MNV-1 crossing the FAE into the PP lamina 
propria in pIgR KO compared to WT B6 mice at either timepoint (Figure 2.7E). These data 
suggest that MNV-1 access to the PP lamina propria is not altered in pIgR KO mice compared to 
controls. 
However, one limitation of the previous experiment is the short interaction time between 
MNV-1 and SIg compared to a natural, oral infection, during which the virus travels through the 
intestinal tract. Therefore, we hypothesized that pre-incubation of MNV-1 with natural SIgA 
may boost virus internalization if performed prior to the ileal loop ligation. Nevertheless, similar 
MNV levels were detected in the PP lamina propria in WT B6 and pIgR KO mice when MNV-1 
was pre-complexed with non-MNV specific SIgA or bovine serum albumin (BSA) as negative  
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  Figure 2.7: Natural secretory immunoglobulins do not aid in MNV-1 access to the Peyer’s 
patch  
A. RAW264.7 cells were exposed to MNV-1 for one hour on ice to allow virus attachment. Unbound 
virus was removed, and dithiothreitol (DTT) was added at varying concentrations for 15 minutes at 
37C. Cells were frozen at -80°C after washing and MNV-1 genome copies were determined via RT-
qPCR. B-F. Intestinal ileal loop assay in WT B6 and pIgR KO mice. 100 l (3.8x10
5
 PFU) MNV-1 
was injected into the closed loop and incubated for 25 or 40 min. Viral genome copy equivalents 
were measured by RT-qPCR in Peyer’s patches. B. Model of intestinal loop assay. C. MNV-1 bound 
to and internalized into the Peyer's patch (PP). Data are pooled from four independent experiments. 
D-E. MNV-1 genomes bound to the follicle-associated epithelium (FAE binding) and internalized 
into the PP lamina propria (FAE crossing) after 25 or 40 minutes. Data are pooled from two 
independent experiments. F. MNV-1 was pre-incubated with rotavirus-specific secretory IgA (SIgA) 
or bovine serum albumin (BSA) for 1 hour at 37°C before injecting the complex into the loop. Data 
are pooled from two independent experiments. Error bars represent standard error of the mean 
(SEM) and each datapoint represents an individual PP. Data were analyzed using Mann Whitney U 
test. ns = not statistically significant. 
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control for MNV-1 binding (Figure 2.7F). Taken together, these data demonstrate that, although 
MNV-1 can interact with recombinant non-specific SIg, natural SIg does not facilitate MNV-1 
binding to or crossing of the intestinal epithelial barrier.  
 
2.2D Polymeric Immunoglobulin Receptor KO Mice Have Increased Numbers of Small 
Intestinal Antigen Presenting Cell (APC) Subsets 
           Since access to the site of primary viral infection, the PP, cannot account for the reduced 
infection seen in pIgR KO mice, I next investigated whether an absolute or relative reduction in 
the number of B cells, macrophages and DC, established MNV target cells [20, 21] in the small 
intestine, might provide an explanation. Small intestines and their PP were collected from naïve 
mice, tissues were digested to create single cell suspensions, and cellularity was analyzed via 
flow cytometry. To determine the correct digestion time to preserve immune cells viability, I 
digested PP samples for 10 to 20 minutes [42] and assessed cellular viability via flow cytometry. 
I determined that cellular viability decreased with increasing digestion time, and that the optimal 
digestion time occurred between 10-13 minutes (data not shown). After harvest and digestion of 
naïve tissues, no difference was detected in the percentage of B cells (CD19+/CD11b-), 
macrophages (CD19-/CD11b+/CD64+), and DCs (CD19-/CD11b+/CD64-/CD11c+) in the 
villous or PP lamina propria (Figure 2.8A-B). No difference was further observed in the number 
of the three APC subsets in the villous lamina propria (Figure 2.8C). Interestingly, all three APC 
subsets were increased roughly 2.5-fold in the PP lamina propria of pIgR KO mice compared to 
controls (Figure 2.8D). These data demonstrate that pIgR KO mice have increased numbers of 
MNV-susceptible cell types at the site of infection. 
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Figure 2.8: PIgR KO mice have increased small intestinal APC subsets  
A-D. Peyer’s Patches and small intestinal lamina propria cells were isolated from naïve pIgR KO 
and WT B6 mice. Live cells were analyzed via flow cytometry. The gating strategy was as follows: 
Antigen-presenting cells (APCs) were defined as Singlets/Live/CD45+/I-A/I-E (MHCII)+. APCs 
were further gated into B cells (CD19+/CD11b-), macrophages (CD19-/CD11b+/CD64+) (M), 
and dendritic cells (CD19-/CD11b+/CD64-/CD11c+) (DCs). A-B. Percentage of live lamina 
propria (A) and Peyer’s patch (B) cells. C-D. Absolute number of live lamina propria (C) and 
Peyer’s patch (D) cells. Data shown are pooled from two to three independent experiments and 
each symbol is a datapoint from an individual animal. The data mean is indicated for each group. 
Data were analyzed using Mann Whitney U test. *= P<0.05. **= P<0.01 ***= P<0.001. ****= 
P<0.0001. ns = not statistically significant. 
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I next performed further phenotyping of macrophage and DC (mononuclear phagocyte) 
subsets via flow cytometry to determine if differences in APC subsets may account for reduced 
viral replication seen in pIgR KO mice. Live cells were first gated on MHCII expression to select 
for all APCs, and CD19 expression was used to exclude B cells from mononuclear phagocytes. 
Mononuclear phagocytes were then characterized into subsets based on expression of CD11b, 
CD103, CX3CR1, and CD8 as previously described [43]. Percentages and absolute numbers of 
stationary mononuclear phagocytes (CD11b-/CD103+/-/CX3CR1-/CD8+) were not different 
between strains and represented the bulk of the mononuclear phagocyte pool (data not shown). 
Analysis of migratory mononuclear phagocytes, termed conventional DCs 
(CD11b+/CD103+/CX3CR1-/CD8-), revealed reduced percentages in pIgR KO villous lamina 
propria compared to controls, however percentages were similar in the PP (Figure 2.9A-B). The 
ability of mononuclear phagocytes to cross-present extracellular antigens to CD8 T cells is 
primarily undertaken by plasmacytoid dendritic cells (CD11b-/CD103+/CX3CR1-/CD8+), while 
CX3CR1 expressing mononuclear phagocyte subsets (CD11b+/CD103-/CX3CR1+/CD8-) 
comprise primarily stationary macrophages and are poor stimulators of T cells [43]. No 
differences in percentages of these subsets in the villous or PP lamina propria were detected 
(Figure 2.9A-B). Despite enhanced percentages of conventional DCs, the number of all 
mononuclear phagocyte subsets were equal in the small intestinal lamina propria of pIgR KO vs. 
control mice (Figure 2.9C). In keeping with enhanced mononuclear phagocyte numbers in the 
PP of pIgR KO mice compared to controls (see Figure 2.8E), numbers of all three mononuclear 
phagocyte populations assessed were enhanced in pIgR KO mice versus controls (Figure 2.9D). 
Taken together with data from Figure 2.7, these data suggest that access to and availability of 
norovirus target cells cannot account for reduced MNV-1-NR infection seen in pIgR KO mice. 
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Figure 2.9: Small intestinal mononuclear phagocyte characterization 
A-D. Peyer’s Patches and small intestinal lamina propria cells were isolated from naïve pIgR KO 
and WT B6 mice. Live cells were analyzed via flow cytometry. The gating strategy was as follows: 
Antigen-presenting cells (APCs) were defined as Singlets/Live/CD45+/I-A/I-E (MHCII)+. 
Mononuclear phagocytes were further defined as CD19- and characterized based on expression of 
CD11b, CD103, CX3CR1 and CD8. A-B. Percentage of live villous lamina propria (A) and 
Peyer’s patch (B) cells. C-D. Absolute number of live villous lamina propria (C) and Peyer’s patch 
(D) cells. Data shown are pooled from two independent experiments and each symbol is a 
datapoint from an individual animal. The data mean is indicated for each group. Data were 
analyzed using Mann Whitney U test. *= P<0.05. **= P<0.01. ns = not statistically significant. 
 65 
2.2E Interferon-ɣ and iNOS Levels are Enhanced in Naïve Polymeric Immunoglobulin 
Receptor KO Mice 
 It is well known that SIg complexes have immunomodulatory functions, and that when 
enteric bacteria are recognized in complex with SIg an anti-inflammatory response is initiated 
[7]. Therefore, I next explored localized mis regulation of PP immunity in pIgR KO mice as a 
source of reduced MNV-1 replication.  Towards that end, transcript levels of a panel of cytokines 
and chemokines were analyzed in naïve and 9 hpi pIgR KO and compared to those from naïve 
and 9 hpi WT B6 mice. The ileum was chosen for assessment, as it is the initial site of MNV-1 
replication and the organ in which MNV-1 titers were significantly reduced at both 9 and 18 hpi 
in pIgR KO mice (Figures 2.2D). Host mRNA was isolated from naïve and 9 hpi ilea of both 
groups of mice and analyzed by RT-qPCR for transcript levels of the anti-inflammatory genes 
TGF- and interleukin 10, the pro-inflammatory and antiviral genes TNF-α, iNOS, IFN-ɣ, IFN-
, IFN-, and ISG15.  IFN-ɣ transcript levels in naive pIgR KO mice were greatly enhanced 
over naive controls (Figure 2.10A). Interestingly, after 9 hours of MNV-1-NR infection IFN-ɣ 
transcript levels were significantly reduced in pIgR KO mice compared to uninfected controls. 
However, infected pIgR KO mice still exhibited enhanced IFN-ɣ transcript levels compared to 
infected WT B6 mice (Figure 2.10A).  
iNOS transcript levels were significantly enhanced in naive pIgR KO mice compared to 
naive WT B6, however similar levels were observed in infected mice of both backgrounds 
(Figure 2.10B). In contrast, IFN- transcript levels were significantly reduced in naive and 
infected pIgR KO mice compared to controls (Figure 2.10C). Similarly, transcript levels of the 
inflammatory molecules TNF-α and ISG15 were comparable in naive and infected pIgR KO 
mice compared to controls (Figure 2.10D-E), as were transcript levels of TGF-, a cytokine  
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Figure 2.10: IFN-ɣ and iNOS levels are enhanced in pIgR KO mice  
A-F. Total ileal RNA was isolated from naïve or 9 hpi pIgR KO and WT B6 mice to determine host 
gene levels in reference to gapdh. Data is shown in reference to WT B6 mice and displayed as 2^-
(ΔΔCT). ΔCT values were analyzed for significance. G. Intestinal segments from naïve pIgR KO 
and WT B6 mice were harvested to determine host IFN-ɣ protein levels via ELISA. Each symbol is 
the datapoint from an individual animal. The data mean is indicated for each group. *= P<0.05. **= 
P<0.01 ***= P<0.001. ns = not statistically significant. 
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which promotes IgA class switching [44] (Figure 2.10F). IFN- and IL-10 were undetectable in 
either group (data not shown). Consistent with increased IFN-ɣ transcript levels, ileal IFN-ɣ 
protein levels were also significantly higher in pIgR KO mice versus WT B6 controls (Figure 
2.10G). No difference in IFN-ɣ levels between strains were found in other sections of the 
intestinal tract (Figure 2.10G), suggesting site specific differences in IFN-ɣ regulation. These 
data demonstrate that pIgR KO mice have enhanced levels of iNOS and IFN-ɣ, consistent with 
previous findings that SIgA dampens inflammatory signals [7]. Both molecules have established 
anti-viral activities [45-48]. No significant mortality is seen in iNOS-deficient mice infected with 
MNV-1 [16], and MNV-1 replicates similarly in bone marrow-derived macrophages from WT 
B6 and iNOS-deficient mice [20]. In contrast, IFN-ɣ is a cytokine, which effectively blocks 
MNV infection [29-32]. Thus, these findings suggest that elevated levels of some antiviral 
cytokines in naïve pIgR KO mice, in particular IFN-ɣ, may limit MNV-1 replication. 
Furthermore, MNV-mediated downregulation of IFN-ɣ in pIgR KO mice suggests viral 
regulation of this antiviral cytokine. 
 
2.2F Small Intestinal Macrophages are Resistant to Norovirus Infection 
         I have found that the naïve pIgR KO mice have enhanced levels of IFN-ɣ and iNOS, 
suggesting that they may be less susceptible to MNV infection. To determine if MNV-1 target 
cells, specifically macrophages, from pIgR KO mice are less susceptible to MNV-1 infection 
than control cells, I derived macrophages from the bone marrow of pIgR KO and WT B6 
animals by culturing isolated cells at 37C in the presence of 20% L929 supernatant [49]. After 7 
days, bone marrow-derived macrophages (BMDM) were infected with MNV-1 and viral 
replication was assessed at 24 and 48 hpi via plaque assay. MNV-1 replication in BMDM peaked 
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at 24 hpi and reached equivalent levels in pIgR KO and control BMDM (Figure 2.11A). Small 
intestinal lamina propria cells were also isolated from pIgR KO and control mice as previously 
described [42]. Once isolated, cells were plated and allowed to adhere overnight at 37C. Non-
adherent cells were removed, and adherent cells were collected using PBS with 0.02% EDTA. 
Collected cells were seeded onto fresh plates and infected with MNV-1 at a MOI of 5 after 
attachment. Interestingly, ex vivo infection of small intestinal lamina propria macrophages was 
not detectable (Figure 2.11B).  
Given that MNV-1 infection initiates in the ileum, I next sought to determine if I could 
detect viral infection in cells separately isolated from the lamina propria of digested duodenum, 
jejunum and ileum of naive pIgR KO mice and controls. These intestinal segments included both 
lymphoid and non-lymphoid tissue after isolation as described above [42]. A preliminary study 
(n=1) using an MOI of 5, showed no increase in viral genome copies by 9 hpi in adherent cells 
isolated from the SI segments (Figure 2.11C-E). However, recent data from the Karst lab 
demonstrated that MNV-1 replication almost exclusively occurs in the PP and not the lamina 
propria [19]. Therefore, I repeated the experiments above using only PP-derived immune cells. 
In order to determine if PP immune cells are differentially susceptible to MNV-1 infection, I 
harvested cells from the PP from pIgR KO mice and controls as described above. I infected both 
adherent and non-adherent cells (MOI of 5) and assessed cultures for MNV-1 infection by plaque 
assay. I detected no enhancement in MNV-1 in either the non-adherent or the adherent fractions 
of cells isolated from the PP of naïve mice from either strain (Figure 2.11F-G).  
Taken together, I determined that bone-marrow derived macrophages from pIgR KO 
mice are equally susceptible to MNV-1 infection as cells derived from WT B6 mice. Although 
most of these findings are preliminary, it appears as though immune cells isolated from the small  
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  Figure 2.11: Small intestinal cells are resistant to MNV-1 infection 
A. Bone marrow was harvested from naïve pIgR KO and WT B6 mice. Bone marrow derived 
macrophages (BMDM) were differentiated for 7 days and infected with MNV-1 at an MOI 
0.05. Viral replication was assessed at indicated times post infection via plaque assay. Data are 
pooled from 3 independent experiments (n=8 mice). B-G. Small intestines were harvested 
from naïve pIgR KO and WT B6 mice. Small intestinal lamina propria and PP cells were 
isolated and incubated overnight at 37C. Adherent cells were collected and infected with 
MNV-1 at an MOI 5. Viral replication was assessed at indicated times post infection via plaque 
assay. B. Data are pooled from 3 independent experiments (n= 8 mice). C-E. Small intestine 
was divided into fifths with the first section representing the duodenum, 2-4 the jejunum, and 
section 5 the ileum. Data are from 1 experiment (n=2 mice). F-G. Small intestinal PP were 
isolated, and cells were pooled per individual mouse. After overnight incubation, both adherent 
and non-adherent cells were collected and infected. Data are from 1 experiment (n=2 mice). 
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intestine are refractory to ex vivo MNV-1 infection regardless of mouse genotype. Despite robust 
infection of BMDM from pIgR KO and control mice, our findings suggest small intestinal cells 
are resistant to ex vivo MNV-1 infection. Numbers of PP macrophages are fairly low however 
and I did not verify the identity of adherent and non-adherent cell populations. Further 
characterization of harvested small intestinal cells is necessary to assure isolation of MNV target 
cell types.  
 
2.2G Interferon-ɣ Reduces Norovirus Infection in vivo 
 Interferon gamma has known anti-MNV activity  [29-33], and its enhancement in the 
ileum of pIgR KO mice compared to WT B6 controls correlates with reduction of MNV 
replication. To test whether enhanced levels of IFN-ɣ limit MNV-1 infection in pIgR KO mice, 
we neutralized intestinal IFN-ɣ in pIgR KO mice via intraperitoneal (i.p.) treatment of 500 µg 
anti-IFN-ɣ, or isotype control antibody 18 hours prior to MNV-1-NR infection. Viral replication 
was measured 18 hpi via plaque assay in intestinal segments as before. While no differences 
were observed in viral titers in either the ileum or the cecum of anti-IFN-ɣ or isotype control-
treated pIgR KO mice (Figure 2.12A-B), there was a significant enhancement in MNV-1 
replication in the colon of pIgR KO mice following IFN-ɣ neutralization (Figure 2.12C). No 
differences were detected in viral loads in the mesentery, duodenum, jejunum and feces between 
the two groups of mice (data not shown). These data suggested that the enhanced levels of IFN-ɣ 
in pIgR KO mice might directly inhibit MNV-1 replication. To confirm these findings, I next 
treated WT B6 mice i.p. with 104 units of IFN-ɣ 18 hours prior to MNV-1-NR infection. Viral 
loads were again determined 18 hpi by plaque assay. Significantly reduced titers were observed 
in both the ileum and the cecum of IFN-ɣ treated WT B6 mice compared to controls (Figure  
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Figure 2.12: IFN-ɣ reduces MNV-1 infection in vivo 
A-C. PIgR KO mice were treated with 500 µg anti-IFN-ɣ antibody or isotype control were 
administered intraperitoneally 18 hours before MNV-1-NR infection. D-F. WT B6 mice were 
treated with 10
4
 units/animal IFN-ɣ or equivalent protein (BSA) intraperitoneally 18 hours prior to 
infection by oral gavage with 3.8x10
5
 PFU/animal of neutral red labeled MNV-1, and tissues were 
harvested at 18 hpi in a darkened room using a red photolight. The tissue homogenate was serially 
diluted and exposed to white light for 30 min. Replicated viral titers in the indicated tissue of WT 
B6 and pIgR KO mice were assessed via plaque assay. The sensitivity threshold for each graph is 
indicated by the dashed line and is as follows (log PFU/g tissue): A. 2.34 B. 2.21 C. 2.14 D. 1.79 
E. 2.22 F. 2.1.  Data are pooled from two independent experiments and each symbol is a data point 
from an individual animal. Error bars are standard error of the mean (SEM). Values were analyzed 
using Mann Whitney U test. *= 0.05 ns = not statistically significant.  
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2.12D-E). No difference in viral replication was seen in the colon (Figure 2.12F).  Similar to our 
findings in pIgR KO mice, no differences were detected in viral loads in the mesentery, 
duodenum, jejunum and feces of IFN-ɣ or control-treated WT B6 mice (data not shown). These 
data confirm the anti-MNV properties of IFN-ɣ in vivo. Taken together, these results point to a 
model in which the absence of SIg results in enhanced IFN-ɣ sufficient to limit MNV-1 
replication in the GI tract. 
 
2.3 Discussion 
SIg provides a first line of defense against several enteric pathogens by reducing 
immunogenicity of lumenal bacterial communities, mediating immune exclusion, and expulsion 
from the host (reviewed in [7, 50, 51]). Despite the ability of recombinant, non-MNV specific 
pIgA, secretory component, and SIgA to bind MNV-1, infection was not altered in vitro, and 
removing SIg-mediated innate intestinal defenses did not alter MNV-1 binding to the FAE, or 
internalization into PP. Instead, our findings demonstrated that pIgR KO mice, which lack SIg, 
showed reduced MNV-1 infection. This suggests natural SIg do not exclude MNV from the 
intestine or mediate intraepithelial expulsion of this virus. More importantly, these data indicate 
that natural SIg do not protect the host from norovirus infection, a finding that also extended to 
reovirus. This result is surprising given other enteric pathogens are controlled in this manner [3-
6]. To the best or our knowledge, this represents the first example in which pIgR and natural SIg 
indirectly promote infection by enteric viruses.  
Our current analysis of pIgR KO mice also revealed previously unrecognized features of 
this mouse strain. First, these mice had ~2.5 fold greater numbers of macrophages, DC and B 
cells in their PP, suggesting larger PP, compared to WT B6 controls. Second, key M cell 
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transcripts (i.e., Spi-B and GP2) were similar to controls, suggesting that M cell development is 
independent of SIg. Third, analysis of host mRNA levels in the small intestine revealed that IFN-
ɣ and iNOS were selectively elevated in naïve pIgR KO mice compared to WT B6 controls. 
Previous studies have also reported enhanced inflammatory activation in pIgR KO mice, 
resulting in lethal systemic hyperactivity [52], spontaneous COPD [53], and enhanced 
susceptibility to chemically-induced colitis [54]. 
Analysis of pIgR KO mice revealed previously unrecognized features of this mouse strain 
summarized pictorially in Figure 2.13. First, we confirmed serum IgA protein levels were 
enhanced in pIgR KO mice compared to WT B6 controls (Figure 2.13 Circle 1).  Second, I 
determined pIgR KO mice had ~2.5 fold greater numbers of B cells in their PP (Figure 2.13 
Circle 2), suggesting enhanced B cell numbers detected previously in the intestinal lamina 
propria [34] are actually localized in the PP. Third, I determined pIgR KO mice also had ~2.5 
fold greater numbers of macrophages and DC in their PP, suggesting larger PP, compared to WT 
B6 controls (Figure 2.13 Circle 3). Interestingly, subsets of the mononuclear phagocytes 
remained unchanged between mouse strains. Fourth, key M cell transcripts (i.e., Spi-B and GP2) 
were similar to controls, suggesting that M cell development is independent of SIg (Figure 2.13 
Circle 4).  
Analysis of host mRNA levels in the small intestinal ileum revealed that IFN-ɣ and iNOS 
were elevated in naïve and 9 hpi pIgR KO compared to WT B6 controls. Enhanced IFN-ɣ 
protein levels were also detected in naïve pIgR KO mice. MNV-1 infection reduced IFN-ɣ 
transcript levels after 9 hpi in pIgR KO mice. Previous studies have also reported enhanced 
inflammatory activation in conventional pIgR KO mice, resulting in lethal systemic hyperactivity 
[52], spontaneous COPD [53], and enhanced susceptibility to chemically-induced colitis [54].  
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Figure 2.13: Small intestinal alterations I found in pIgR KO compared to WT B6.  
Diagram of small intestinal villi and PP from WT B6 (C57/Bl6) and pIgR KO mice. 
PIgR KO mice lack Sig in the intestinal lumen and as such exhibit enhanced serum IgA 
(1). PIgR KO mice also have enhanced B cells (2), macrophages, and dendritic cells (3) 
in the small intestine PP compared to WT B6 controls. However, M cell levels remain 
unchanged (4) in pIgR KO mice compared to controls. 
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These data point to a model in which reduced MNV-1 replication following oral infection is due 
to local immunological alterations at the FAE barrier in the absence of secretory 
immunoglobulins. We hypothesize pIgR KO specific enhancement of IFN-ɣ is mediated by 
microbial sensing, a hypothesis I will be testing in Chapter 3. 
All positive-sense single stranded RNA viruses form replication complexes in the cytosol 
of infected cell to facilitate viral replication [23], and this process is disrupted during MNV 
infection by IFN-ɣ [32]. My data in addition to previously acknowledged anti-norovirus activity 
of IFN-ɣ [29, 32, 55], suggest that the reduced MNV-1 infection in pIgR KO mice is a direct 
result of enhanced levels of IFN-ɣ in the intestines of pIgR KO mice compared to WT B6 
controls.  
It has been shown that SIg localize in the outer mucus layer with bacteria, and that these 
interactions may limit bacterial access to the epithelial surface. Therefore, it is possible that 
without SIg, intestinal bacteria have enhanced access to the epithelial barrier contributing to the 
enhanced inflammatory cytokines found in conventional pIgR mice versus controls (see Figure 
2.10). A thorough investigation of the mucus layer in the absence of SIg has been performed, and 
no difference in mucus thickness or bacterial localization was seen in pIgR KO compared to WT 
B6 mice [56]. These data suggest that the enhanced IFN-ɣ and iNOS found in naïve conventional 
pIgR KO mice is due to the immunomodulatory functions of SIg within the host interior. 
A recent study determined that innate immune cell detection of serum IgA via the IgA 
receptor (FcR1) in conjunction with pattern recognition receptor activation, resulted in a 
synergistic enhancement of pro-inflammatory cytokine production and release [57]. 
Additionally, FcR1 engagement by CD103+ DCs has been shown to result in enhanced 
inflammatory cytokine release and promotion of pro-inflammatory T cell activation [58]. These 
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studies provide a possible explanation for the enhanced inflammatory molecules I observed in 
pIgR KO animals, as we (data not shown), and others [36, 37] have detected elevated serum IgA 
levels compared to WT B6 controls. I posit that enhanced serum IgA levels, coupled with altered 
bacterial communities and a lack of SIg sensing, may result in an improperly controlled immune 
response to enteric commensals in pIgR KO mice. Therefore, studies in Chapter 3 are aimed to 
dissect the role of the intestinal microbiota in the SIg-mediated enhancement of enteric virus 
infection. 
Interestingly, the observed increase in inflammatory immune responses was not uniform, 
i.e., elevated iNOS and IFN-ɣ levels in conventional pIgR KO mice, reduced IFN-, and no 
change in transcript levels of other pro-and anti-inflammatory mediators (see Figure 2.10). The 
reason for this remains unclear. One potential explanation may come from the observed increases 
in the number of APC subsets (DCs, macrophages and B cells) in the PP of pIgR KO mice 
compared to WT B6 controls. These cell types have both FcR1 and pathogen recognition 
receptors and are capable of pro-inflammatory cytokine secretion [57, 59-62]. Another potential 
source for the enhanced pro-inflammatory cytokines in pIgR KO mice may be intra-epithelial 
lymphocytes (IELs), which are enhanced in the small intestines of these mice [63, 64] and which 
upon activation exhibited more abundant IFN-ɣ secretion than WT B6 IELs [63]. Of note, 
activation of IELs via the T cell receptor in vivo resulted in significant reduction of MNV titers 
in the small intestine and MLN of WT B6 mice [65]. That study may point to a potential cell 
type that could mediate the antiviral activity in pIgR KO mice, but future studies are required to 
investigate this hypothesis.  
Our study further highlights the importance of the intestinal cytokine milieu for optimal 
MNV pathogenesis. Recent findings suggest that MNV-1 induces lysis of infected cells via the 
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VP1 domain of the viral capsid. This inflammatory lytic cell death was found to be pro-viral as it 
results in recruitment of myeloid cells which in turn increases the local concentration of MNV 
susceptible cells[66]. However, our data demonstrates that MNV infection is reduced in pIgR 
KO mice (see Figure 2.2), despite elevated levels of inflammatory molecules (see Figure 2.10) 
and enhanced numbers of MNV target cells versus controls (see Figure 2.8). 
IFN-ɣ has well-recognized anti-norovirus activity [29-33], and our findings provide 
direct evidence for IFN-ɣ mediated inhibition of MNV replication in vivo. IFN-ɣ treatment of 
small intestinal organoid cultures resulted in a marked increase in the inflammatory cytokines 
TNF-α, IL-1, and IL-6 as well as antimicrobial peptides [67]. IFN-ɣ treatment also enhanced 
reactive oxygen and nitrogen species [67] which is consistent with our findings in pIgR KO mice 
(see Figure 2.10A-B). Under both conditions of IFN-ɣ modulation, neutralization and addition, 
MNV-1 titers were altered in some regions of the intestine (see Figure 2.12). Interestingly, viral 
loads in intestinal segments were differentially affected by each treatment, which may be due to 
regionalization of the intestinal immune system [68]. Reovirus titers in the lower gastrointestinal 
tract were also reduced in pIgR KO mice compared to WT B6 controls, further emphasizing the 
role of pIgR in facilitation of enteric viral infection.  
Taken together, these experiments demonstrate that contrary to other enteric pathogens, 
SIg do not protect from MNV or reovirus infection, but that instead the presence of pIgR and SIg 
promotes infection. Thus, both molecules are host factors that can have either anti- or pro-
microbial functions depending on the pathogen. Lastly, our data further highlight that MNV and 
reovirus as enteric pathogens have optimized infection under conditions of intestinal 
homeostasis. When these conditions are perturbed, such as the absence of pIgR and SIg, virus 
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infection is compromised. In the future, it will be interesting to test whether this holds true for 
other enteric viral infections. 
 
2.4 Materials & Methods 
 
Animals. C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME) and 
housed in SPF- and MNV-free conditions. A breeder pair of PIgR knockout mice on a C57BL/6 
background (B6.129P2-Pigrtm1Fejo/Mmmh, stock number: 030988-MU) was obtained from Drs. 
Stappenbeck and Virgin (Washington University, St. Louis, MO). All mice were bred and 
housed in SPF-, MNV-, and reovirus-free conditions. Age and sex matched experimental mice 
were used between 6 and 16 weeks of age. Mice used in the study were seronegative for anti-
MNV antibodies by enzyme-linked immunosorbent assay (ELISA) as described previously [20]. 
Animal studies were performed in accordance with local and federal guidelines. The protocol 
was approved by the University of Michigan Committee on Use and Care of Animals (UCUCA 
number PRO00006658). 
 
Viral Stocks. The plaque-purified MNV-1.CW3 (GV/MNV-1/2002/USA) virus stock (herein 
referred to as MNV-1) was generated as previously described [69]. A neutral red-labeled MNV-1 
(MNV-1-NR) (3.8x106 PFU/mL), and MNV-CR3 stock (MNV-CR3-NR) (3x106 PFU/mL), were 
generated from MNV-1 and MNV-CR3 (GV/CR3/2005/USA) passage 6, as previously described 
[35]. MNV-1-NR and MNV-CR3-NR was handled in a darkened room using a red photolight 
(Premier OMNI) and stored in a light safe box at -80°C. To assess MNV-1-NR light inactivation, 
stocks of MNV-1-NR were exposed to white light or left in darkness and samples were taken 
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every 5 minutes to assess light mediated reduction in viral titer via plaque assay. Reovirus 
recombinant T1L stocks were generated with reovirus cDNAs in baby hamster kidney-T7 cells 
(a kind gift from Dr. Terence Dermody, University of Pittsburgh) [70, 71], followed by plaque 
purification, and passage in L929 cells [72]. 
 
Animal Infections. Mice were infected via oral gavage (o.g.) with 3.8 x 105 PFU MNV-1-NR or 
2.6x105 PFU MNV-CR3-NR in 100 l/mouse in a red light only room. For neutralizing antibody 
treatment of pIgR KO mice, 500 µg anti-IFN-ɣ antibody (rat IgG, clone XMG1.2, eBioscience), 
or isotype control (Rat IgG, clone HRPN, InVivoMab) were administered intraperitoneally 18 
hours before MNV-1-NR infection. For IFN-ɣ treatment of B6 mice, 104 units IFN-ɣ 
(PeproTech) or equivalent weight bovine serum albumin fraction V (BSA) (Roche) was diluted 
in PBS, filtered with 0.22 micron filter (Fisher Scientific), and administered intraperitoneally 18 
hours before MNV-1-NR infection. Mice were infected via o.g. with 3.8 x 105 PFU MNV-1-NR 
in 100 l/mouse in a red light only room. Mice received intraperitoneal infection of 3.8 x 105 
PFU MNV-1-NR in 100 l/mouse in a red light only room. Tissues were harvested at 9,  18, or 
48 hpi as previously described [17] with the following modifications: 2 cm of tissue was 
collected in pre-weighed tubes containing 1.0 mm diameter zirconia/silica beads (BioSpec), flash 
frozen in an ethanol/dry ice bath, weighed, and stored at -80°C. Mice were infected via o.g. with 
2x106 PFU of reovirus T1L. Tissues were harvested at 24 hpi and processed as described for 
MNV, with the modification that 1 cm of tissue was collected.  
 
Plaque Assay. Homogenized samples were exposed to white light for 30 min to inactivate input 
virus. Light exposure reduced MNV-1-NR titers by 3 logs. The plaque assay was performed as 
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previously described [73]. Reovirus viral titers of homogenized samples was determined by 
plaque assay as described previously using L929 cells [72]. Samples without detectable 
replicated virus were assigned 10 PFU/ml as the lowest detectable unit. Data were normalized to 
the tissue weight and expressed as PFU per gram of tissue. The sensitivity threshold was 
determined for each organ by averaging the PFU/gram tissue of all samples without detectable 
viral titers. 
 
Intestinal Transit Assay. To measure intestinal transit time, mice were fasted for 18 h, gavaged 
orally with 100 ml 50 mg/ml Evans Blue solution prepared with 1% methylcellulose and 
euthanized 15 min later. The small intestine was divided into fifths and each piece was minced in 
0.1 M sodium hydroxide, 6 mM N-acetylcysteine, sonicated, and the absorbance at 565 nm 
determined as previously described [74]. 
 
RNA Isolation. Total RNA was extracted from tissues using TRIzol® Reagent (ThermoFisher 
Scientific) following the manufacturers guidelines. Contaminating genomic DNA was removed 
by treating samples with Turbo DNA free DNase kit (ThermoFisher Scientific). Total RNA was 
quantified using a spectrophotometer (NanoDrop) and stored at -80°C. 
 
Quantitative Real-Time PCR. To measure host cell transcripts, cDNA was generated with 100 
μg of total RNA using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad 
#1708841) in a thermocycler (Eppendorf Mastercycler Epgradient PCR machine) and stored at -
20°C. cDNA was analyzed for levels of Gapdh [75], GP2 [75], Spi-B [75], interferon-gamma 
(IFN-ɣ) [76], interferon-beta (IFN-) [76], tumor necrosis factor-alpha (TNF-) [76], inducible 
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nitric oxide synthase (iNOS) [77], interferon stimulated gene 15 (ISG15) [78], transforming 
growth factor-beta (TGF-) [79], interleukin-10 (IL-10) [80], interferon-lambda (IFN-) [78] in 
a Biorad CFX96 Real Time System qPCR machine using Sso Advanced Universal SYBR Green 
Supermix (Bio-Rad). Gene expression was normalized to transcript levels of the endogenous 
host gene Gapdh, and fold change was calculated relative to WT B6 controls using the delta 
delta CT method [81]. Quantification of MNV-1 genome equivalents in host tissue was 
performed as previously described [69]. 
 
MNV-1 Neutralization assay. MNV-1 (2.8x107 PFU) was pre-incubated with 0.25 mg/ml 
recombinant SIgA [82] or 0.25 mg/mL bovine serum albumin fraction V (Roche) diluted in 1x 
PBS for 1 hour in 37°C water bath, and neutralization was assessed via plaque assay. 
 
Ligated Intestinal Loops and Controls. To test the effect of dithiothreitol (DTT) on virus 
attachment, 5x105 RAW264.7 cells were plated per well in 6 well tissue culture treated plates 
(Corning) and incubated at 37C. After overnight attachment, cells were exposed to MNV-1 for 
one hour on ice to allow virus to attach. Unbound virus was washed away, and cells were 
incubated for 15 min with 0, 1, or 5 mM DTT (Sigma-Aldrich) in 1x PBS (Gibco) at 37°C. Cells 
were frozen at -80°C after washing, RNA was isolated, and MNV-1 genome copies were 
determined via RT-qPCR as described above. 
For ligated intestinal loop studies, mice were anesthetized and placed on a 37°C heating 
pad. A ~2 cm section of the ileum was tied gently on either side of a PP using silk surgical suture 
thread. Approximately 0.1 ml MNV-1 (6.7x107 PFU/mL) was injected as the loop was closed. 
The PP was excised 25 or 40 min later. Mucus was removed by a 10 min incubation with 5 mM 
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DTT (Sigma-Aldrich) in 1x phosphate buffered saline (PBS) (Gibco) in a 37°C water bath. The 
FAE was removed by shaking the PP at 250 rpm (MaxQ 600, Thermo Scientific) for 20 min in 
1x PBS containing 5 mM EDTA (Fluka Analytical) and washed twice with 1x PBS. 
Disassociation of the FAE from the lamina propria was confirmed via flow cytometry using Ep-
CAM (diluted 1:50, clone G8.8, PE, Biolegend). Ep-CAM negative cells (i.e. PP lamina propria) 
were washed twice with 1x PBS by gently inverting the tubes. Cells were placed in 500 l 
RNALater (Sigma) and stored at -80°C.  
For SIgA:MNV complex formation, MNV-1 (2.8x107 PFU) was pre-incubated with 0.25 
mg/ml recombinant SIgA [82] or 0.25 mg/ml bovine serum albumin fraction V (Roche) diluted 
in 1x PBS for 1 hour at 37°C before adding to the loop and treated as described above. 
 
Tissue Digestion/ Flow Cytometry. PP and small intestine lamina propria were dissected from 
naive PIgR KO and WT B6 mice and digested as previously described [42]. 2x106 cells were 
then used for flow cytometric analysis. Viable cells were identified (Invitrogen Live/Dead 
fixable Aqua Dead Cell stain Kit) and then stained for the following surface markers: CD45 
(diluted 1:200, clone 30-F11, AF700, Biolegend), I-A/I-E (diluted 1:50, clone M5/114.15.2, 
PE/Dazzle 594, Biolegend), CD19 (diluted 1:50, clone 6D5, PerCP/Cy5.5, Biolegend), CD11b 
(diluted 1:50, clone M1/70 APC/Cy7, Biolegend), CD64 (diluted 1:50, clone X54-5/7.1 FITC, 
Biolegend) CD11c (diluted 1:50, clone N418 PE/Cy7, Biolegend) CD103 (diluted 1:25, clone 
2EZ, APC, Biolegend), CX3CR1 (diluted 1:50, clone SA011F11, PE, Biolegend), CD8 (diluted 
1:100, clone 53-6.7, APC-Cy7 Biolegend). All antibodies were diluted in FACS buffer; 5% fetal 
bovine serum (Hyclone) and 0.1% sodium azide (Sigma) in 1x PBS, for 30 min on ice. After 
surface staining, cells were fixed for 10 min on ice using Cytofix/Cytoperm (BD Biosciences), 
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washed and fluorescence was analyzed with a BD LSRfortessa. Data was analyzed using FlowJo 
software (BD Biosciences) using the following gating strategy: live cells, CD45 and I-A/I-E 
(MHCII) positive APC were characterized into B cells (CD19+) and mononuclear phagocytes 
(CD19-/CD11b+), which were further delineated into macrophages (CD64+/CD11c-) and DCs 
(CD64-/CD11c+). 
 
Expression and Purification of proteins. MNV-1 capsid protein protruding (P) and shell (S) 
domains were bacterially expressed, and recombinant proteins purified as previously described 
[83]. Recombinant, rotavirus-specific mouse SIgA, IgA dimer, or secretory component were 
expressed and purified as described [84]. 
 
Isolation, and Infection of Bone Marrow Derived Macrophages and Intestinal Cells. In a 
sterile biological safety cabinet, the hind legs and small intestines of pIgR KO and WT B6 mice 
were harvested. Hind legs were kept whole in BM20 media (10 % low endotoxin FCS (Gibco), 
20 % L929-cell Supernatant harvested as described previously [49], 5 % Horse Serum (Gibco), 1 
% L/glutamine (Gibco), 1 % sodium pyruvate (Gibco), 1 % Penicillin Streptomycin (Gibco), in 
low endotoxin DMEM (Gibco)) on ice until femurs were harvested. Femurs were isolated from 
the tissue of the hind leg and cut at the ends to expose the marrow. Bone marrow was flushed out 
using a 26 gauge needle (Fisher Scientific) attached to a 10 ml syringe (Fisher Scientific) with 5 
ml BM20 media per femur. Bone marrow was collected in a 50 ml conical tube (Falcon), and 
after thorough mixing cells were counted and plated into non-TC treated 10 cm plates (Fisher 
Scientific) at a density of 1x107 cells per dish in 10 ml BM20. Cells were incubated at 37C and 
10 ml BM20 was added 4 days later. After 7 days total incubation, medium was removed, and 
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cells are washed with 5 ml ice-cold low endotoxin PBS (Gibco). 2 ml of ice-cold low endotoxin 
PBS with 0.02% EDTA (Fisher Scientific) was added and the cells were incubated at 4C for 10 
minutes to aid in detachment. Cells were dislodged via gentle pipetting, pooled for each mouse, 
and counted. Cells were plated into 12 well TC plates (Corning) at a density of 2.5x106 cells per 
well and were allowed to adhere incubating overnight at 37C. Small intestines and Peyer’s 
patches were digested as described above for flow cytometry [42]. Cells were counted and plated 
into non-TC treated 10 cm plates (Fisher Scientific) at a density of 1x107 per dish in 10 ml 
intestinal macrophage media (10% FBS (Corning), 1mM HEPES (Gibco), 50mM b-
mercaptoethanol (Gibco), 2mM L-glutamine (Gibco), 1mM Sodium Pyruvate (Gibco), 1% 
Penicillin Streptomycin (Gibco), and 1% MEM-non-essential amino acids (Gibco), In RPMI 
(Gibco)). Cells were allowed to adhere overnight. For infection, media was removed, and cells 
were infected with MNV-1 at a MOI of 5 for one hour on ice. Once virus inoculum was washed 
away, fresh media was added, and cells were incubated at 37C for 0, 24, or 48 hours before 
being frozen at -80C. Cells were thawed and frozen again and viral titers were determined by 
plaque assay.  
 
Statistical Analysis. Unless otherwise stated, data were analyzed using Mann Whitney U test 
with GraphPad Prism software version 7 (GraphPad Software, La Jolla, CA). *= P<0.05. **= 
P<0.01 ***= P<0.001. ****= P<0.0001. ns= not significant. 
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Chapter 3: Results 
 
Bacterial Modulation of Norovirus Infection 
 
The text presented in this chapter was published in Viruses, Volume 10, Issue 5, Pages 237-252; 
2018 and Trends in Molecular Medicine, Volume 22, Issue 12, Pages 1047-1059; 2016. Some 
text and figures presented in this chapter were published as a “Spotlight” article of significant 
interest in The Journal of Virology 92:e00826-18. https://doi.org/10.1128/JVI.00826-18 
 
3.1 Introduction  
Overlying the epithelial barrier, in the lumen of the gastrointestinal tract is a mucus layer 
that is continuously replenished by goblet cells [1]. The mucus layer acts as a barrier, reducing 
microbial access to the epithelial surface. New mucus is continually produced, and intestinal 
microbes get sloughed off with the old layer. Bacteria exist within the mucus layer of the 
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small intestine. In the large intestine they are only present in the thick, loose outer mucus 
layer while the thinner inner layer remains relatively sterile. Bacterial products however are 
capable of diffusing through the mucus layer, and epithelial cell sensing of bacterial products 
through microbe-associated molecular pattern receptors stimulates cells of the epithelial barrier 
to produce mucus and anti-microbial peptides, and to express the polymeric immunoglobulin 
receptor (pIgR) on the basolateral surface of the epithelial barrier [2, 3]. 
PIgR shuttles immunoglobulins into the intestinal lumen through epithelial cells to form 
secretory immunoglobulins (SIg) and secretory component (SC) [2]. SIg and SC directly bind to 
intestinal microbiota through receptor- and carbohydrate-mediated interactions [2]. This binding 
aids in regulation of bacterial species at mucosal surfaces and is an important aspect of mucosal 
defense [4]. Transcytotic microfold cells within the follicle-associated epithelium take up the 
luminal SIg:bacteria immune complexes and translocate them into the intestinal lamina propria 
[5]. Immediately underlying the microfold cells are dendritic cells which sample the SIg immune 
complexes [6] resulting in production of anti-inflammatory mediators IL-10 and TGF- and T 
regulatory cell differentiation, which contribute to tolerance and intestinal homeostasis [7]. 
Intestinal bacteria have many beneficial functions for the host, beyond tolerance 
induction including digestion of insoluble fibers. Bacteria are able to process these fibers into 
forms in which we can digest and extract nutrients from, aiding in nutrient consumption and 
energy absorption [8]. Intestinal commensal bacteria can also protect the host from infection by 
occupying certain physical and nutritional niches within the intestinal lumen, and utilization of 
these nutrients prevents colonization by pathogenic bacteria [9]. Furthermore, several bacterial 
species produce antibiotics that may directly prevent abundant colonization of harmful species 
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[10]. Bacteria have also been shown to modulate viral infections [11], including norovirus [12, 
13]. 
Both HNoVs and MNVs have been reported to bind carbohydrate moieties [14-18], 
including sialic acid residues which are widely expressed on bacteria [19]. One such group of 
carbohydrate residues, histo-blood group antigens (HBGAs), are attachment factors that facilitate 
binding of some caliciviruses to cells [20-22]. To date, a direct interaction of HNoV capsids with 
members of the microbiota is known for a few commensal (e.g., Enterobacter cloacae) and 
pathogenic (e.g., Clostridium difficile) bacterial species [22, 23]. However, more direct 
norovirus:bacteria interaction pairs are sure to be uncovered over time. 
Experimentally induced bacterial dysbiosis has been shown to alter MNV infection. For 
instance, pretreatment of mice with an antibiotic cocktail of vancomycin, ampicillin, 
metronidazole, and neomycin reduces acute MNV- 1 titers [12] and reduces or prevents infection 
by persistent MNV strains MNV-3 and MNV-CR6, respectively [12, 13]. Importantly, MNV-
CR6 viral loads are restored with a fecal transplant from untreated to antibiotic-treated animals 
[13]. Although antibiotic treatment reduces intestinal MNV titers, it is not an advisable treatment 
option for HNoV infections, given the overall beneficial impact of the microbiota on human 
health [24].  At the cellular level, co-infection of macrophages with MNV and various bacteria 
has been shown to reduce viral titers, likely stemming from bacterial triggering of innate immune 
responses, while at the same time fostering bacterial growth through MNV-induced inhibition of 
inflammatory cytokines [25-27].  
Although not universally seen, both HNoV and MNV can alter host gut microbial 
communities under certain conditions. This dysbiosis typically results in an enhanced bacterial 
Firmicutes-to-Bacteroidetes (F/B) ratio, an alteration also linked to liver fibrosis and obesity [28, 
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29]. A subset (20%) of HNoV-infected individuals exhibited enhanced F/B ratios [30], while 
MNV-1 enhanced F/B ratios in C57BL/6 mice at Day 5 post infection [31]. However, 
longitudinal analyses of both C57BL/6 mice infected with MNV-1, or MNV-CR6, and Swiss 
Webster mice infected with MNV-1, or MNV-4 failed to detect MNV-induced dysbiosis of 
gastrointestinal bacteria at the phylum level [32]. A reduction in intestinal Lactobacillus strains 
occurred in MNV-1-infected ICR mice, with a concurrent increase in Proteobacteria delta, 
mirroring findings from HNoV [32]. 
SIg and SC are highly glycosylated [33], as such we hypothesized that MNV would 
associate with SIg in the intestinal lumen and this interaction would modulate MNV infection. 
To investigate this further, mice lacking SIg due to a deficiency in pIgR (pIgR KO) were used in 
studies described in Chapter 2. Briefly, I determined that MNV-1 viral loads were reduced in the 
gastrointestinal tract of pIgR KO mice compared to C57BL/6 controls (WT B6) (see Figure 2.2), 
despite equal access to, and enhanced numbers of MNV target cells (DCs, macrophages, and B 
cells) in the PP of pIgR KO mice (see Figure 2.7 and 2.8). Instead, I found that compared to WT 
B6 mice, naive pIgR KO mice had enhanced levels of interferon gamma (IFN-ɣ) (see Figure 
2.10), a cytokine known to inhibit MNV replication [34-38]. Neutralization of IFN-ɣ in pIgR KO 
mice, or addition of IFN-ɣ to WT B6 mice enhanced and reduced MNV-1 viral loads 
respectively (see Figure 2.12). Taken together, my findings in Chapter 2 support a model 
whereby immune cell sensing of SIg downmodulates antiviral cytokine levels, thereby promoting 
enteric viral infection. Although it is clear that IFN-ɣ is capable of modulating MNV infection, 
the inducer of the enhanced IFN-ɣ in pIgR KO mice remained unexplored. Given that SIg-
mediated bacterial sensing results in tolerogenic immune responses [4], I hypothesized that 
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altered bacterial sensing due to lack of SIg in pIgR KO mice resulted in enhanced IFN-ɣ and 
reduced MNV infection compared to WT B6 mice. 
To determine if altered bacterial sensing resulted in enhanced IFN-ɣ levels seen in the 
absence of SIg, I modulated intestinal microbial communities in pIgR KO, B6, and Swiss 
Webster mice and determined the effect on MNV infection. I found that, in the absence of 
intestinal microbiota, lack of secretory immunoglobulins no longer enhance baseline IFN-ɣ 
levels as was seen in conventionally housed mice. Despite similar baseline levels, germ-free 
pIgR KO mice had enhanced anti-MNV responses; exhibiting more IFN-ɣ protein, and enhanced 
mRNA levels of interferon stimulated gene-15 (ISG15) after MNV-1 infection than germ-free 
controls. Despite the upregulated anti-MNV response germ-free pIgR KO mice, MNV-1 
replication in the gastrointestinal tract was equivalent to that of germ-free controls at 18 hpi. I 
also determined that intestinal microbiota alter MNV-1 and MNV-CR3 intestinal regionalization, 
and this regionalization may not be explained by access to and availability of MNV target cells. 
Taken together, these data point to a model in which intestinal bacteria modulate MNV intestinal 
regionalization, and indirectly modulate the local microenvironment to favor MNV infection 
through SIg-mediated microbial sensing.  
 
3.2 Results 
3.2A Intestinal Microbial Communities Are Altered in PIgR KO Mice 
 Alterations in the intestinal microbiota in the absence of SIg, coupled with the lack of SIg 
sensing by intestinal immune cells, may skew immune activation and account for the 
upregulation of IFN-ɣ and iNOS seen in naive pIgR KO mice compared to controls (see Figure 
2.10). Previous reports regarding microbial alterations in the gastrointestinal tract of pIgR KO 
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mice are conflicting [39, 40]. Therefore, I sterilely collected feces and luminal contents as well 
as intestinal mucosa tissue from the ileum and cecum of naïve pIgR KO and WT B6 mice 
originating from the same breeding locations as used in the infection experiments in Chapter 2. 
With the help of Christine Bassis and the UM Microbiome and Metabolomics Core, I determined 
the microbial composition of the ileal contents, ileum, cecal contents, cecum, and feces via 16S 
rRNA gene sequencing. Intestinal microbial community differences were assessed via analysis of 
molecular variance (AMOVA), and overall alpha-diversity of the microbial community was 
assessed via inverse Simpson analysis (invsimpson). 
PIgR KO mice had equivalent diversity as compared by invsimpson analysis in their ileal 
contents compared to naïve WT B6 mice, but exhibited enhanced Firmicutes populations 
including Clostridiales, Lactobacillus, and Erysipelotrichaceae species resulting in significantly 
altered microbial communities by AMOVA (Figures 3.1A-B). The ileum lamina propria of pIgR 
KO mice was less diverse than the lumen by invsimpson analysis, however microbial 
communities were still significantly altered compared to WT B6 mice, again exhibiting enhanced 
Erysipelotrichaceae species colonization (Figures 3.1C-D). The microbial communities present 
in the cecal contents, cecum (including the cecal patch), and feces of pIgR KO mice were also 
significantly altered by AMOVA and more diverse by invsimpson analysis compared to WT B6 
communities and showed enhancement in the Firmicutes species (Clostridiales, Lactobacillus, 
and Erysipelotrichaceae) also found in pIgR KO ileal contents (Figures 3.1E-J). The microbial 
community in the cecum had the highest diversity by invsimpson analysis, more than the cecal 
contents. Interestingly, WT B6 mice also had significant differences in microbial communities 
based on breeding room for all locations tested. However, differences between WT B6 and pIgR 
KO mice were much greater than differences among WT B6 mice. The microbial communities  
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Figure 3.1: Intestinal microbial communities are altered in pIgR KO mice  
A-J. Lumenal contents, and mucosal lamina propria of the ileum and cecum as well as feces were 
sterilely isolated from naive pIgR KO and WT B6 mice and intestinal microbial communities were 
anaylzed via 16S rRNA gene sequencing. A, C, E, G, I. Principal coordinates analysis (PCoA) 
plot of θ
YC
 distances between bacterial communities is shown as analyzed by analysis of molecular 
variance (AMOVA). Each symbol represents the bacterial community from an individual animal. 
Closed symbols represent WT B6 mice, and shapes distinguish between WT B6 breeding rooms. 
Open circles represent pIgR KO mice. B, D, F, H, J. Box & Whisker graphs of inverse Simpson 
(invsimpson) analysis of microbial diversity. Each box denotes interquartile range with line at 
mean. Whiskers show minimum and maximum values. Five mice per group. K. Ileal contents were 
isolated from the ileum of naïve WT B6 and pIgR KO mice. After 100 micron filter pass through, 
ileal contents were weighed and incubated with 1.34x10
7
 PFU MNV-1 for one hour at room 
temperature. Samples were then washed, RNA was isolated, and viral genome copies were 
assessed via RT-qPCR. Data are pooled from three independent experiments and each symbol is a 
data point from an individual animal. Error bars are standard error of the mean (SEM). Data were 
analyzed using Mann Whitney U test. ns = not statistically significant. 
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were significantly altered in pIgR KO mice compared to WT B6 controls in all sites analyzed by 
AMOVA. Our findings are consistent with the study by Reikvam et al. [40] and demonstrate that 
intestinal microbial communities are significantly altered in pIgR KO mice. These alterations 
may contribute to a skewed intestinal cytokine milieu. 
To determine if the altered bacterial communities in pIgR KO mice altered MNV-1 
bacterial binding in the lumen, I collected, filtered, and weighed ileal luminal contents and 
incubated contents with MNV-1. After an hour unbound virus was washed away, and viral 
genome copies were assessed via RT-qPCR. I found that ileal luminal contents bound MNV-1 
equally well between pIgR KO and WT B6 mice (Figure 3.1K). These data suggest that, despite 
alterations in the microbiome of pIgR KO mice versus WT B6 controls, MNV can bind to ileal 
luminal contents equally. Taken together, these data suggest that SIg alter the microbial 
composition and diversity in the intestinal lumen and mucosal tissue, and these microbial 
alterations may be indirectly influencing MNV-1 infection in pIgR KO mice. 
 
3.2B Antibiotic Treatment of Conventional PIgR KO Mice Reduces MNV-1 Replication 
 Antibiotic treatment of WT B6 mice has been shown to reduce MNV-1 infection [13, 41]. 
To determine if bacterial populations modulate MNV-1 infection in the absence of secretory 
immunoglobulins, I treated pIgR KO mice with antibiotics and infected them with MNV-1-NR. I 
used the antibiotic cefoperazone, a broad-spectrum antibiotic that targets both gram-positive and 
gram-negative bacteria [42]. Short-term antibiotic treatment will reduce the bacterial load while 
at the same time avoiding physiological (e.g., villus length, Peyer’s patch development) and 
immunological (e.g. immune cell development, antibody production) differences seen in germ-
free versus conventional mice [42-46]. I first determined that antibiotic treatment reduced 
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bacterial loads in the small intestine after MNV infection by harvesting intestinal contents. I 
observed that antibiotically treated pIgR KO mice had no visually detectable bacterial colony 
formation, whereas conventional pIgR KO mice had bacteria able to form many colonies greater 
than 1.2 mm in size as defined by an aCOLyte colony counter (Figure 3.2A).  
 To determine the effect of bacteria on MNV infection in the absence of SIg and SC, 
antibiotically treated and control pIgR KO mice were infected with 3.8 x 105 PFU MNV-1-NR 
via oral gavage and titers of replicated virus were assessed via plaque assay at 18 hpi. 
Determination of MNV-1 replication in these mice revealed very little detectable replication of 
MNV-1 in the mesentery, and small intestine (Figure 3.2B-E). MNV-1 replication was 
detectable in the cecum and colon of conventionally housed mice; however, no replication was 
detected in antibiotically treated pIgR KO mice (Figure 3.2F-G). The MNV-1 distribution in the 
conventionally housed pIgR KO mice was primarily detected in the cecum and colon, whereas 
MNV-1 was primarily detected in the ileum and cecum of WT B6 controls, the reason for this 
shift in tropism remains unknown. No statistically significant differences in MNV-1 shedding 
were detected between treatment groups (Figure 3.2H). These data suggest that short-term 
reduction in bacterial communities of pIgR KO mice significantly reduces MNV-1 viral 
replication, and are consistent with findings from Baldridge et al., which determined that pIgR 
KO mice exhibited reduced fecal shedding of MNV-CR6 at 7 dpi after antibiotic treatment as 
compared to conventional control pIgR KO mice [13]. These data suggest bacterial species 
enhance MNV infection in the absence of secretory immunoglobulins. This is in contrast to data 
from WT B6 mice, which showed no change in MNV-1 titers after antibiotic treatment [13].   
 
3.2C IFN-ɣ and iNOS Levels are Similar in Naive Germ-Free PIgR KO and WT B6 Mice 
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Figure 3.2: Intestinal microbiota enhance MNV-1 infection in pIgR KO mice  
A-H. Conventionally housed pIgR KO mice were given untreated, or cefoperazone 
[0.5g/L] treated distilled water for 7 days. Mice were infected by oral gavage with 
3.8x10
5
 PFU/animal of neutral red labeled MNV-1, and tissues and intestinal contents 
were harvested at 18 hpi in a darkened room using a red photolight. A. Intestinal contents 
were isolated and after 100 micron filter pass through, contents were weighed, and an 
equal amount was serially diluted in LB broth. Aliquots from each dilution was plated 
onto BHI plates and colonies >1.2 mm were assessed after overnight incubation at 37˚C. 
The -1 dilution of intestinal contents is shown. B-H. Intestinal tissue homogenate was 
serially diluted and exposed to white light for 30 min. Replicated viral titers in the 
indicated tissue of antibiotically treated and conventional pIgR KO mice were assessed 
via plaque assay. The sensitivity threshold for each graph is indicated by the dashed line 
and is as follows (log PFU/g tissue): B. 2.23 C. 2.035 D. 2.148 E. 2.357 F. 2.123 G. 
2.041 H. 1.127. Data are pooled from two independent experiments and each symbol is 
a data point from an individual animal. Error bars are standard error of the mean (SEM). 
Values were analyzed using Mann Whitney U test. **= P<0.01.  ns = not statistically 
significant. 
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 Bacterial sensing in the absence of SIg results in inflammatory cytokine production [2], which 
may disrupt MNV-1 replication. To test whether enhanced levels of cytokines limit MNV-1 
infection in pIgR KO mice, I first sought to identify a condition in which the levels of IFN-ɣ and 
iNOS were similar between pIgR KO and WT B6 mice. Since SIgA dampens the inflammatory 
signals of commensal bacteria [2], we hypothesized that germ-free mice of both backgrounds 
might represent one such condition.  Thus, both pIgR KO and WT B6 mouse strains were 
rederived germ-free. 
To determine if intestinal microbiota are necessary for the immunomodulatory functions 
of MNV-1 seen in conventionally housed mice, namely reduced IFN-ɣ in pIgR KO mice and 
reduced IFN- and TNF- in WT B6 mice (see Figure 2.10), I infected germ-free pIgR KO and 
WT B6 mice with 3.8 x 105 PFU MNV-1-NR via oral gavage and assessed host cytokine 
responses in comparison to naïve germ-free mice at 18 hpi via RT-qPCR. 
 Contrary to conventionally infected animals, ileal IFN-ɣ, iNOS IFN-, TNF-, and TGF-
 transcript levels were comparable between naïve and infected pIgR KO mice and WT B6 
controls devoid of bacterial stimulation (Figure 3.3A-D & 3.3F). Also contrary to 
conventionally housed animals, ISG15 transcript levels were enhanced after MNV-1 infection in 
germ-free pIgR KO mice compare to uninfected germ-free controls as well as infected germ-free 
WT B6 (Figure 3.3E). Although no change in IFN-ɣ transcripts was detected after MNV-1 
infection, IFN-ɣ protein levels were significantly enhanced in pIgR KO mice compared to 
infected germ-free WT B6 controls (Figure 3.3G), this may account for the enhanced ISG15 
transcript levels seen in infected germ-free pIgR KO mice. 
 These data demonstrate that removal of the microbiota is able to equalize small intestinal 
IFN-ɣ and iNOS levels in naive pIgR KO and WT B6 mice, highlighting the immunomodulatory  
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Figure 3.3: IFN-ɣ and iNOS Levels are reduced in 
germ-free pIgR KO mice  
A-H. Germ-free WT B6 mice were infected by oral 
gavage with 3.8x10
5
 PFU/animal of neutral red 
labeled MNV-1, and tissues were harvested at 18 hpi. 
A-F. Total ileal RNA was isolated from infected and 
naïve germ-free pIgR KO and WT B6 mice. Host 
gene levels were normalized to gapdh. Data is shown 
in reference to WT B6 and displayed as 2^-(ΔΔCT). 
ΔCT values were analyzed for significance using 
Mann Whitney U test. G. Ileal IFN-ɣ protein levels 
via ELISA from infected and naïve germ-free pIgR 
KO and WT B6 mice.  Each symbol is a data point 
from an individual animal. Error bars are standard 
error of the mean (SEM). Data were analyzed using 
Mann Whitney U test. *= P<0.05. **= P<0.01. ns = 
not statistically significant. 
  106 
functions of SIg. Furthermore, these data suggest that bacteria aid in MNV-1-mediated 
immunomodulation. 
 
3.2D MNV-1 Infection is Similar in Germ-Free PIgR KO and WT B6 Mice 
           The previous findings suggest that in the absence of pIgR and SIg (i.e. pIgR KO mice), 
inflammatory responses to enteric bacteria may create an inhospitable environment for MNV-1 
infection. To test this hypothesis, I infected germ-free pIgR KO and WT B6 mice with 3.8 x 105 
PFU MNV-1-NR via oral gavage and assessed titers of replicated virus via plaque assay at 18 
hpi. Consistent with our hypothesis, germ-free pIgR KO and WT B6 had similar viral loads 
throughout the entire gastrointestinal tract (i.e., duodenum, jejunum, ileum, cecum, colon) and 
MLN as well as similar viral shedding in the feces (Figure 3.4A-G). In addition, it is worth 
noting that similar with previous studies using antibiotic-depleted WT mice [12] and data shown 
above (see Figure 3.3), overall virus loads were reduced in germ-free compared to conventional 
WT B6 mice. These data demonstrate that MNV-1 replicates similarly in pIgR KO and WT B6 
mice under conditions where inflammatory markers such as IFN-ɣ and iNOS are equivalent.  
 
3.2E Bacteria Alter MNV-1 Gastrointestinal Regionalization 
Although direct interaction of MNV with bacteria has not yet been demonstrated, MNV 
binds to glycoproteins that can be found on bacterial surfaces [14, 47]. My studies have revealed 
that a reduction in microbial communities after antibiotic treatment of pIgR KO mice resulted in 
reduced MNV-1 infection compared to untreated controls. These data are consistent with 
previous findings [13], and suggest bacterial species enhance MNV infection in the absence of 
SIg. When bacteria were removed from experimental conditions, antiviral cytokine levels and  
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Figure 3.4: MNV-1 infection is similar in germ-free pIgR KO and WT B6 mice 
A-G. Germ-free pIgR KO and WT B6 mice were infected by oral gavage with 3.8x10
5
 
PFU/animal of neutral red labeled MNV-1, and tissues were harvested at 18 hpi in a darkened 
room using a red photolight. The tissue homogenate was serially diluted and exposed to white 
light for 30 min. Replicated viral titers in the indicated tissue of germ-free WT B6 and pIgR 
KO mice were assessed via plaque assay. The sensitivity threshold for each graph is indicated 
by the dashed line and is as follows (log PFU/g tissue): A. 2.356 B. 2.881 C. 2.057 D. 2.317 
E. 2.014 F. 2.077 G. 1.993. Data are pooled from four independent experiments and each 
symbol is a data point from an individual animal. Error bars are standard error of the mean 
(SEM). Values were analyzed using Mann Whitney U test. ns = not statistically significant. 
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MNV-1 replication were similar between germ-free pIgR KO and WT B6 mice (see Figure 3.3) 
but not between the conventionally housed counterparts (see Figure 2.10). Taken together these 
data support a model in which SIg modulate intestinal bacterial communities and these bacterial 
communities in turn modulate MNV infection.  
To study these trans-kingdom interactions in more detail, I infected conventional and 
germ-free C57/Bl6 mice with 3.8 x 105 PFU MNV-1-NR via oral gavage and assessed viral 
replication at 9 hpi via plaque assay. I found that there was little MNV-1 replication in the 
mesentery of either conventional or germ-free mice (Figure 3.5A). In the duodenum, germ-free 
mice exhibited detectable viral replication in 10/15 mice, while only 2/14 conventional mice had 
detectable viral replication (Figure 3.5B). Thus, MNV-1 replication was significantly increased 
in the duodenum of germ-free mice. Viral replication in the jejunum was not altered between 
conventionally housed and germ-free housed mice (Figure 3.5C). In contrast, conventionally 
housed mice had significantly more MNV viral replication and more mice (9/14) in the ileum 
than germ-free housed animals (1/15) (Figure 3.5D). Although more conventionally housed 
mice had detectable viral replication in the cecum (6/14 conv. vs. 1/15 germ-free), it failed to 
reach statistical significance (Figure 3.5E). No differences in MNV replication were detected in 
the colon (Figure 3.5F). Taken together these results suggest that the small intestinal region 
where MNV-1 infection is initiated is altered in germ-free animals versus conventionally housed 
controls, which is surprising given intestinal bacteria are primarily located in the colon [1]. 
 Reduced viral replication in the ileum at this early time post infection could suggest that 
MNV-1-NR access to the distal small intestine is altered in germ-free mice versus conventional 
controls. To determine if the enhanced MNV-1 replication in the proximal small intestine, and 
the reduced MNV-1 replication in distal small intestine is due to intestinal trafficking differences  
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Figure 3.5: Intestinal regionalization of MNV-1 is altered in the absence of the 
microbiome 
A-F. Germ-free or conventionally housed WT B6 mice were infected by oral gavage with 
3.8x10
5
 PFU/animal of neutral red labeled MNV-1, and tissues were harvested at 9 hpi in a 
darkened room using a red photolight. The tissue homogenate was serially diluted and 
exposed to white light for 30 min. Replicated viral titers in the indicated tissue of germ-free 
WT B6 and pIgR KO mice were assessed via plaque assay. The sensitivity threshold for each 
graph is indicated by the dashed line and is set to 200. Viral titers are shown as log PFU/mL 
tissue. Data are pooled from four independent experiments. Values were analyzed using Mann 
Whitney U test. *= P<0.05. ***= P<0.001. ns = not statistically significant. G. Evans blue 
dye was administered to fasting conventional and germ-free B6 mice. After 15 minutes the 
stomach and small intestine were harvested. The small intestine was divided into fifths and 
transit of the dye was measured by absorbance at 562 nm. Data are pooled from two 
independent experiments. Data was analyzed using 2-way ANOVA. Each symbol is a data 
point from an individual animal. Error bars are standard error of the mean (SEM).  
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in conventionally housed versus germ-free housed mice, I performed an intestinal transit assay. 
Conventional and germ-free B6 mice were fasted for 18 hours. Evan’s blue dye was diluted into 
1x PBS with 1% methylcellulose and administered via oral gavage. 15 minutes after 
administration, the stomach and small intestinal segments were harvested and processed, and 
absorbance of Evans blue dye was assessed in each segment as a readout of peristalsis rate. I 
determined that there was no difference in intestinal transit rate as Evans blue dye was 
distributed similarly in conventional and germ-free housed B6 mice (Figure 3.5G). These data 
suggest that MNV-1-NR can reach the distal small intestine equally well in germ-free and 
conventional controls and cannot account for the altered regionalization in MNV-1 infection seen 
in germ-free mice. Taken together, these data demonstrate that MNV-1 infection of the small 
intestine is altered in the absence of the intestinal microbiota and suggest that intestinal bacteria 
modulate the regionalization of the MNV-1 replication site. 
  
3.2F Bacteria Alter MNV-CR3 Gastrointestinal Regionalization 
 Bacterial facilitation of MNV infection was shown for MNV-1 [11, 12], however 
the effect of bacteria on other MNV strains has not been explored. To determine the effects of 
bacteria on MNV-CR3 infection, I infected germ-free and conventionally housed mice with 
2.6x105 PFU MNV-CR3-NR via oral gavage and assessed viral replication at 12 hpi via plaque 
assay. These preliminary (n=1) findings showed that after the first round of viral replication, very 
little virus was detectable in the mesentery (Figure 3.6A). Similar to MNV-1 replication, MNV-
CR3-NR replication also exhibited altered small intestinal distribution. Detection of viral 
replication was highest in the proximal small intestine in germ-free housed animals, with less 
virus detected in the more distal small intestine whereas viral replication in conventionally 
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housed animals was opposite (Figure 3.6B-D). Little replicated virus was detected in the colon 
and feces at this early time point for either group (Figure 3.6E-F). These data show that MNV-
CR3 intestinal distribution is altered in the absence of intestinal microbiota. Taken together with 
Figures 3.2 and 3.5, these data demonstrate that the intestinal location of MNV infection is 
reduced in an MNV strain-independent manner when the intestinal microbiota is reduced or 
absent. 
 
3.2G Distribution of Small Intestinal Immune Cells is Not Altered Under Germ-Free 
Housing Conditions 
 Germ-free animals have several abnormalities including less vascularized intestinal villi, 
thinner mucus layer, and an underdeveloped immune system, SIg production, and lymphoid 
follicle maturation versus conventionally housed animals [46].  MNV-1 has been shown to infect 
T and B cells [12], dendritic cells and macrophages [48], therefore, alterations in these 
populations could account for the altered intestinal distribution in germ-free housed mice versus 
controls. In order to determine if the immune cell distribution in our naive germ-free housed 
mice was dysregulated compared to naive conventionally housed control mice, I assessed the 
distribution of the small intestinal immune cells via flow cytometry in different intestinal 
segments. Intestinal segments were harvested and digested as previously described to create 
single cell suspensions [49]. Immune cell subsets were defined as B and T cells, NK cells, 
neutrophils, macrophages, dendritic cells, and eosinophils and were distinguished using cell 
markers outlined in Table 3.1.  
These preliminary studies (n=1, 3 mice/group) show no differences in B cell populations 
across the small intestine for either group, and no differences between germ-free and  
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Figure 3.6: Intestinal regionalization of MNV-CR3 is altered in the absence of the 
microbiome 
A-F. Germ-free and conventional WT B6 mice were infected by oral gavage with 2.6x10
5
 
PFU/animal of neutral red labeled MNV-CR3, and tissues were harvested at 12 hpi in a darkened 
room using a red photolight. The tissue homogenate was serially diluted and exposed to white light 
for 30 min. Replicated viral titers in the indicated tissue of germ-free WT B6 and pIgR KO mice 
were assessed via plaque assay. The sensitivity threshold for each graph is indicated by the dashed 
line and is set at 10. Viral titers are displayed as log PFU/mL tissue. Data are from one experiment 
and each symbol is a data point from an individual animal. Error bars are standard error of the 
mean (SEM). Values were analyzed using Mann Whitney U test. ns = not statistically significant. 
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CD11b CD11c CD19 CD49b Ly6C Ly6G TCRb SSCA 
B Cells - 
 
+ 
     
T Cells - 
  
- 
  
+ 
 
NK Cells 
   
+ 
  
- 
 
Neutrophils High - - - - + 
  
Macrophages + - - - + - 
 
Low 
Dendritic Cells + + - - 
    
Eosinophils + - - - - + 
 
High 
Table 3.1: Characterization of Small Intestinal Immune Cells  
Immune cell subsets characterized in Figure 3.7 were defined as B and T cells, 
Natural Killer (NK) cells, neutrophils, macrophages, dendritic cells, and eosinophils 
and were distinguished using cell surface markers outlined above using flow 
cytometry. SSCA= side scatter area. 
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conventional animals were evident throughout the small intestine (Figure 3.7A-B). There is a 
trend toward fewer percentages of T cells across the small intestine in germ-free housed mice 
versus controls, however these preliminary data (n=1, 3 mice/group) are not significantly 
different, nor is the absolute number of T cells (Figure 3.7C-D). No differences were notable in 
natural killer cells either across the small intestine or between housing conditions (Figure 3.7E-
F). Similar to natural killer cells, no differences were notable in the neutrophil compartment 
either across the small intestine or between housing conditions (Figure 3.8A-B). Macrophage, 
dendritic cell (DC) and eosinophil populations were reduced in percentage distally throughout 
the small intestine in both housing conditions, however absolute numbers appear constant 
throughout the SI segments (Figure 3.8C-H). These preliminary results suggest that the 
percentage and number of immune cell subsets across the small intestine may be comparable in 
germ-free and conventionally housed mice, and that access to MNV target cells cannot account 
for the altered intestinal distribution of MNV in germ-free housed mice versus controls. 
However, additional repeats are needed to confirm these findings. 
 
3.2H Bacteroides thetaiotaomicron Colonization of Germ-Free Mice Does Not Enhance 
MNV-1 Infection 
Secretory immunoglobulins, intestinal transit, and MNV target cell distribution cannot 
explain the altered intestinal distribution MNV in bacteria-deplete conditions. Further 
exploration of the mechanism behind this altered tissue tropism led us to explore norovirus-
bacterial interactions. It is clear that optimal MNV infection occurs in the context of a robust 
microbiome. To more readily delineate a mechanism in the future, I next sought to determine if  
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Figure 3.7: Distribution of small intestinal adaptive immune cells are not altered under germ-
free housing conditions 
A-F. Small intestinal segments were isolated from naïve germ-free (GF) and conventional WT B6 mice 
(Conv.) and lamina propria cells were isolated. Live single cells were analyzed via flow cytometry, 
and B, T and natural killer cells were defined as outlined in Table 3.1. A, C, E. (left column) Percentage 
of live cells indicated on graph. B, D, F. (right column) Absolute number of live cells indicated on 
graph. Data shown are from one experiment and each symbol is a data point from an individual animal. 
Error bars are standard error of the mean (SEM). Data were analyzed using Mann Whitney U test. ns 
= not statistically significant. 
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Figure 3.8: Distribution of small intestinal innate immune cells are not altered under germ-free 
housing conditions (on following page) 
A-H. Small intestinal segments were isolated from naïve germ-free (GF) and conventional WT B6 mice 
(Conv.) and lamina propria cells were isolated. Live single cells were analyzed via flow cytometry, and 
neutrophils, macrophages, dendritic cells and eosinophils were defined as outlined in Table 3.1. A, C, 
E, G. (left column) Percentage of live cells indicated on graph. B, D, F, H. (right column) Absolute 
number of live cells indicated on graph. Data shown are from one experiment and each symbol is a data 
point from an individual animal. Error bars are standard error of the mean (SEM). Data were analyzed 
using Mann Whitney U test. ns = not statistically significant. 
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the beneficial nature of bacteria-replete conditions in MNV infection could be recapitulated with 
a single bacterial species. Previous work by Dr. Juliana Bragazzi-Cunha in the Wobus lab 
determined that the MNV-1 P-domain of the viral capsid is capable of binding to Bacteroides 
thetaiotaomicron (B. theta) via the SusD protein (not shown). The binding of B. theta SusD 
recombinant protein to the P-domain of the MNV-1 capsid led us to hypothesize that B. theta 
SusD binding aids in MNV-1 attachment to target cells as was shown with the H-antigen of 
Enterobacter cloacae and human norovirus [12]. Furthermore, we hypothesized that B. theta 
colonization and interaction with MNV may be able to restore MNV tissue tropism in germ-free 
animals to that of conventional controls. 
 To determine if B. theta colonization of germ-free mice can restore the shift in intestinal 
regional tropism observed in the germ-free mice in comparison to conventionally housed mice, 
we monocolonized germ-free Swiss Webster mice with B. theta by orally gavaging a one-time 
dose of 108 bacteria. After two weeks of colonization, I infected B. theta monocolonized and 
germ-free Swiss Webster mice with 3.8 x 105 PFU MNV-1-NR via oral gavage and assessed 
viral replication at 9 hpi via plaque assay. To determine if monocolonization of B. theta was 
successful, I first analyzed the small intestinal contents of MNV-1-NR infected mice for 16S 
DNA levels. Unfortunately, only 2 of the 5 B. theta monocolonized mice had detectable 16S 
DNA bands after PCR amplification (Figure 3.9A). 
Furthermore, I found that colonization with B. theta did not alter MNV-1 regionalization 
seen in germ-free housed mice versus conventionally housed controls (see Figure 3.5) as MNV-
1 replication was primarily detected in the duodenum in both germ-free and B. theta colonized 
cohorts (Figure 3.9C). There was no significant difference in MNV-1 viral loads between germ-
free and B. theta colonized mice in any organ, and mice with detectable 16S DNA in their small  
  121 
  A. 
C. B. 
E. 
D. 
F. 
1 2 3 4 5 1 2 3 4 5 
Germ Free B. theta 
G. 
  122 
 
  
Figure 3.9: Monocolonization with Bacteroides thetaiotaomicron may not alter MNV-1 
regionalization 
A-G. Germ-free Swiss Webster mice were either untreated or colonized via oral gavage with 
1x10
9
 colony forming units of Bacteroides thetaiotaomicron (B. theta) for 2 weeks before 
infection by oral gavage with 3.8x10
5
 PFU/animal of neutral red labeled MNV-1. Tissues and 
intestinal contents were harvested at 9 hpi in a darkened room using a red photolight. A. DNA 
was isolated from intestinal contents and a culture of B. theta grown overnight in LB broth at 
37˚C. 16S rDNA was amplified via PCR and visualized using gel electrophoresis. B-G. The 
tissue homogenate was serially diluted and exposed to white light for 30 min. Replicated viral 
titers in the indicated tissue of germ-free and B. theta colonized Swiss Webster mice were 
assessed via plaque assay. The sensitivity threshold for each graph is indicated by the dashed 
line and is set at 10. Viral titers are displayed as log PFU/mL tissue. Data are from two 
independent experiments and each symbol is a data point from an individual animal. Error bars 
are standard error of the mean (SEM). Values were analyzed using Mann Whitney U test. ns = 
not statistically significant. 
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intestinal lumen (red squares) showed no obvious differences from their 16S undetectable B. 
theta colonized cohort (black squares), or germ-free mice (Figure 3.9B-G).  These data suggest 
the MNV-1 binding to intestinal commensal B. theta was not capable of altering the intestinal 
regionalization of MNV-1 infection of germ-free mice, and thus the physical interaction may not 
be the main driver of the regionalization differences. However, future studies are needed to 
confirm these findings in additional animals. 
 
3.3 Discussion 
In this study I sought to determine if enhanced IFN-ɣ levels seen in the absence of SIg 
and SC were due to differences in immune sensing of bacterial communities in pIgR KO mice vs 
B6 Controls. I found that intestinal microbial communities are altered in the absence of SIg and 
the immune response to bacteria in the absence of SIg is skewed toward inflammation, as no 
enhancement in IFN-ɣ and iNOS transcripts were seen in naïve germ-free pIgR KO compared to 
germ-free B6. I also determined that MNV-1 was able to replicate to similar levels in germ-free 
mice regardless of SIg in contrast to conventionally housed pIgR KO mice which showed 
reduced MNV-1 replication in multiple organs throughout infection compared to controls, 
suggesting bacterial sensing in the presence of SIg is beneficial for MNV infection. Furthermore, 
antibiotic treatment of pIgR KO mice suggests that intestinal bacteria can modulate MNV 
infection in the absence of SIg sensing. These data, and findings outlined in Chapter 2, point to a 
model in which SIg indirectly promote norovirus infection through immune sensing of microbial 
communities. In this study I also sought to directly examine the role of bacteria in MNV 
pathogenesis. My findings revealed an altered intestinal distribution of MNV-1 and MNV-CR3 
in germ-free mice compared to conventional WT B6 controls. This shift in regionalization could 
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not be explained by intestinal transit differences or MNV target cell availability or recapitulated 
with B. theta. Collectively, these data and published studies [12, 50] demonstrate that intestinal 
bacteria both directly and indirectly modulate norovirus infection.  
In the case of MNV, infection of antibiotic-treated mice results in decreased MNV loads 
in the ileum [12, 50], and commensal bacteria promote MNV persistence in the intestine via 
modulation of type III interferon responses [13]. Our microbiome analysis revealed that different 
bacterial communities could support optimal MNV infection as no difference was seen in MNV-
1 viral replication between WT B6 breeding facilities despite significant microbiome differences 
(see Figure 3.1 and Figure 2.2). However, MNV infection was inhibited in pIgR KO mice when 
the intestines were inflamed, and a different microbial community was present compared to WT 
B6 controls. Direct assessment of microbial communities in naïve pIgR KO and WT B6 mice 
revealed enhanced Firmicutes species were present throughout the pIgR KO intestinal tract 
compared to WT B6 controls (see Figure 3.1), and these mice consistently exhibited decreased 
MNV-1 infection (see Figure 2.2). Interestingly, HNoV [30] and MNV [31] infection can both 
result in enhanced Firmicutes species contributing to intestinal microbial dysbiosis, however 
whether enhancement in Firmicutes species is detrimental to norovirus infection remains 
untested.  
I found that, after initial detection at 9 hpi, MNV-1 viral titers increased throughout the 
time course in the ileum of WT B6 mice. However, there was no detectable MNV-1 infection in 
the ileum after the initial round of replication in pIgR KO mice compared to WT B6 mice (see 
Figure 2.2). MNV-1 infection appears to favor the cecum and colon at later times post infection 
(see Figure 2.2 and Figure 3.2), perhaps due to the lower levels of IFN-ɣ found in those tissues 
compared to the ileum (see Figure 2.10G). 
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Norovirus infections are modulated directly and indirectly by the presence of commensal 
bacteria [11]. In case of MNV, infection of antibiotic-treated mice results in decreased MNV 
loads in the ileum [12, 50], and commensal bacteria promote MNV persistence in the intestine 
via modulation of type III interferon responses [13]. My preliminary (n=1, 4 mice/group) 
findings in antibiotically treated pIgR KO mice show reduced infection compared to 
conventional pIgR KO controls (see Figure 3.2). Furthermore, I determined that MNV infects 
germ-free pIgR KO and WT B6 mice similarly regardless of SIg and SC (see Figure 3.5). 
Together these data suggest that bacterial modulation of MNV infection is not dependent on SIg 
or SC. 
In combination with results from Chapter 2 (see Figure 2.2), MNV-1 infection was 
reduced only in conventional pIgR KO mice, which exhibited elevated levels of intestinal iNOS 
and IFN-ɣ, but not in their germ-free counterpart, when naïve cytokine levels were similar to WT 
B6 mice. Since IFN-ɣ has well-recognized anti-norovirus activity [34-37], these data suggest that 
the immune response generated towards the enteric microbiota in the absence of SIg was capable 
of inhibiting norovirus replication. Enhanced ISG15 transcript levels were detected after MNV-1 
infection of germ-free pIgR KO animals, but not germ-free WT B6 controls. These data suggest 
that, in the absence of tolerizing secretory immunoglobulins, at least parts of the immune 
response to MNV-1 infection may be enhanced. This enhancement in ISG15 transcripts in 
infected germ-free pIgR KO mice was not seen in conventionally housed pIgR KO animals 
(compare Figure 2.10E to 3.3E) and could suggest bacterially-mediated immune suppression. 
Reduction in IFN- and TNF- levels seen in naive and infected conventional pIgR KO mice 
compared to WT B6 controls was not recapitulated in germ-free conditions (compare Figure 
2.10C-D to 3.3C-D), again suggesting that reduction in immune mediators is driven by the 
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intestinal microbiota. Together these results suggest that intestinal bacteria not only modulate 
MNV-1 infection but may also impact the resulting anti-viral immune response.  
However, my data is not the first example of bacterially-mediated alterations in viral 
immunity. Similar observations have been demonstrated in rotavirus infection, with reduced 
bacterial species resulting in enhanced anti-rotaviral immunity regardless of viral burden [51]. 
Intestinal bacterial species can also modulate enteric viral infection directly. Similar to human 
norovirus [11, 12], both reovirus [52] and rotavirus [51] target cell entry is enhanced by the 
presence of intestinal bacteria, as is viral replication. Additionally, mouse mammary tumor virus 
(MMTV) utilizes bacterially-derived lipopolysaccharide to engage host pathogen recognition 
receptor toll-like receptor-4 (TLR-4) which promotes immune responses that are favorable for 
MMTV infection and host immune evasion [53, 54].  
Under germ-free conditions, the intestinal distribution of MNV-1 is similar in both pIgR 
KO and WT B6 mice and is skewed (more virus in proximal intestine) compared to conventional 
WT B6 mice (compare Figure 2.2 & Figure 3.4). However, in conventionally housed pIgR KO 
and WT B6 mice the intestinal distribution of MNV-1 is different between mouse strains (see 
Figure 2.2). These data suggest that intestinal distribution of MNV is dependent on bacteria 
regardless of the presence of SIg and SC. Previous studies regarding virus bacterial interactions 
have revealed that bacterial components can help to stabilize the poliovirus viral capsid resulting 
in increased infection and transmission [52, 55], however whether bacterial components stabilize 
MNV remains unexplored. It is possible that as MNV progresses through the harsh intestinal 
luminal environment virions become increasingly unstable without bacterial products to stabilize 
the capsid, resulting in reduced infection of the distal small intestine observed in germ-free 
animals.  
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My preliminary (n=1) studies of naive germ-free versus conventionally housed mice 
showed no differences in intestinal immune cell distribution throughout the small intestine. 
However, additional experimentation is needed before conclusions can be drawn as these 
findings are contrary to previous studies which show bacteria stimulate B and T cell populations 
[45].One potential reason for the lack of expansion in immune cell subsets in conventionally 
housed animals compared to germ-free housed animals may be attributed to the cleanliness of 
our animal facility. Since MNV is endemic in animal facilities across the country [56], great 
precaution is taken to minimize potential pre-exposure to MNV in our facility. Another potential 
reason could be the collection and digestion method used for analysis. I analyzed both lymphoid 
and non-lymphoid tissue together, however perhaps if I had analyzed them separately minor 
differences would be revealed. Although more work must be done, the current studies into these 
trans-kingdom interactions suggest that intestinal bacteria modulate MNV infection and 
distribution throughout the gastrointestinal tract. 
Investigation into the mechanism of altered intestinal distribution of MNV in germ-free 
mice led us to hypothesize that altered intestinal motility might account for the reduced MNV-1 
infection in the distal small intestine (see Figure 3.2). Previous studies investigating intestinal 
motility under germ-free conditions measured transit of yttrium 91, which was significantly 
delayed in germ-free mice after intragastric administration compared to conventional controls 
[43]. Twelve week antibiotic (ampicillin and neomycin) treatment of conventional C3H/HeOuJ 
mice resulted in increased stool retention and reduced defecation compared to untreated controls 
suggesting bacterial modulation of intestinal motility [57]. Despite these previously seen 
differences in gastrointestinal transit, I did not find any differences between germ-free and 
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conventional control animals. There may be several reasons for this discrepancy including varied 
detection methods, mouse strains, and bacterial colonization status. 
Several studies have suggested bacterial interactions aid in norovirus infection [11-13]. 
However, preliminary results from Swiss Webster mice after confirmed monocolonization of B. 
theta (d, red squares) suggest that MNV-1 binding to intestinal bacteria may not always facilitate 
MNV-1 infection. B. theta used in this study were grown under conditions shown to stimulate 
SusD expression [58] and therefore mediate MNV binding. However, the presence of SusD was 
not confirmed, and could account for the lack of change in MNV-1 distribution after B. theta 
colonization compared to germ-free controls. In the future, it would be interesting to determine if 
B. theta binding to MNV-1 will enhance target cell attachment, and if robust B. theta 
colonization is sufficient to correct intestinal distribution of MNV-1 viral replication seen in 
germ-free mice compared to conventional controls.  
Taken together, my work suggests intestinal commensal bacteria are capable of 
modulating: 1. MNV distribution throughout the gastrointestinal tract, 2. MNV viral loads, and 3. 
anti-MNV host immunity through secretory immunoglobulins. These studies highlight the need 
for further trans-kingdom studies to understand the complex intestinal threesome between host, 
bacteria, and norovirus.  
 
3.4 Materials & Methods 
 
Animals. C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME) and 
housed in SPF- and MNV-free conditions. A breeder pair of PIgR knockout mice on a C57BL/6 
background (B6.129P2-Pigrtm1Fejo/Mmmh, stock number: 030988-MU) was obtained from Drs. 
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Stappenbeck and Virgin (Washington University, St. Louis, MO). All mice were bred and 
housed in SPF- and MNV-free conditions. Germ-free C57/BL6, Swiss Webster, and pIgR KO 
mice were derived and housed in University of Michigan Germ-Free and Gnotobiotic facilities. 
Germ-free status was verified regularly through fecal analysis and necropsy. Age and sex 
matched experimental mice were used between 6 and 16 weeks of age. Mice used in the study 
were seronegative for anti-MNV antibodies by enzyme-linked immunosorbent assay (ELISA) as 
described previously [48]. Animal studies were performed in accordance with local and federal 
guidelines. The protocol was approved by the University of Michigan Committee on Use and 
Care of Animals (UCUCA number PRO00006658). 
 
16S rRNA gene Sequencing. The Microbial Systems Molecular Biology Laboratory 
at the University of Michigan provided 16S rRNA gene sequencing and analysis of samples. 
DNA was isolated with a MagAttract PowerMicrobiome DNA/RNA Kit (Qiagen) using an 
epMotion 5075 liquid handling system. The V4 region of the 16S rRNA gene was amplified and 
sequenced as described previously except using a MiSeq Reagent Nano Kit v2 (500-cycles)[59]. 
The 16S rRNA gene sequence data was processed and analyzed using the software package 
mothur (v.1.40.2) and the most recent MiSeq SOP [60, 61]. After sequence processing and 
alignment to the SILVA reference alignment (release 128) [62], sequences were binned into 
operational taxonomic units (OTUs) based on 97% sequence similarity using the OptiClust 
method [63]. A total of 2212 sequences per sample were subsampled and samples with fewer 
than 2212 sequences were not included in the analysis. By calculating θYC distances (a metric 
that takes relative abundances of both shared and non-shared OTUs into account) [64] between 
communities and using analysis of molecular variance (AMOVA) [65] it was possible to 
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determine if there were statistically significant differences between the microbiota of different 
groups. Principal coordinates analysis (PCoA) was used to visualize the θYC distances between 
samples by plotting in R (version 3.5.1). We also investigated the microbial diversity via Inverse 
Simpson (invsimpson) analysis as well as taxonomic composition of the bacterial communities 
by classifying sequences within mothur using a modified version of the Ribosomal Database 
Project (RDP) training set (version 16) [66, 67]. 
 
Viral Stocks. The plaque-purified MNV-1.CW3 (GV/MNV-1/2002/USA) virus stock (herein 
referred to as MNV-1) was generated as previously described [14]. A neutral red-labeled MNV-1 
(MNV-1-NR) (3.8x106 PFU/mL), and MNV-CR3 stock (MNV-CR3-NR) (3x106 PFU/mL), were 
generated from MNV-1 and MNV-CR3 (GV/CR3/2005/USA) passage 6, as previously described 
[68]. MNV-1-NR and MNV-CR3-NR was handled in a darkened room using a red photolight 
(Premier OMNI) and stored in a light safe box at -80°C. To assess MNV-1-NR light inactivation, 
stocks of MNV-1-NR were exposed to white light or left in darkness and samples were taken 
every 5 minutes to assess light mediated reduction in viral titer via plaque assay.  
 
MNV-1 Ileal Contents Binding Assay. Ileal contents were removed from naïve pIgR KO and 
WT B6 mice and contents were allowed to pass through a 100 micron strainer by flushing with 
10 mLs of cold 1x PBS. PBS was removed, and pass-through contents were collected after 
centrifugation (10,000 rpm 5 min). Contents were weighed and resuspended in 500 l PBS and 
equal weight of ileal contents was added to wells of a 96 well U bottom plate (Fisher Scientific). 
Contents were spun down (10,000 rpm 1 min) to remove 1xPBS and were resuspend in 200 l 
(1.34x107 PFU) MNV-1. After an hour incubation at room temperature, contents were washed 
  131 
with 1 ml 1x PBS, spun down (10,000 rpm 1 min), and supernatant was discarded. This process 
was repeated twice to remove unbound MNV-1 and contents were stored in RNALater at -80˚C 
until RNA isolation as described below. 
 
RNA Isolation. Total RNA was extracted from tissues using TRIzol® Reagent (ThermoFisher 
Scientific) following the manufacturers guidelines. Contaminating genomic DNA was removed 
by treating samples with Turbo DNA free DNase kit (ThermoFisher Scientific). Total RNA was 
quantified using a spectrophotometer (NanoDrop) and stored at -80°C. 
 
Quantitative Real-Time PCR. To measure host cell transcripts, cDNA was generated with 100 
μg of total RNA using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad 
#1708841) in a thermocycler (Eppendorf Mastercycler Epgradient PCR machine) and stored at -
20°C. cDNA was analyzed for levels of Gapdh [69], GP2 [69], Spi-B [69], interferon-gamma 
(IFN-ɣ) [70], interferon-beta (IFN-) [70], tumor necrosis factor-alpha (TNF-) [70], inducible 
nitric oxide synthase (iNOS) [71], interferon stimulated gene 15 (ISG15) [72], transforming 
growth factor-beta (TGF-) [73], interleukin-10 (IL-10) [74], interferon-lambda (IFN-) [72] in 
a Biorad CFX96 Real Time System qPCR machine using Sso Advanced Universal SYBR Green 
Supermix (Bio-Rad). Gene expression was normalized to transcript levels of the endogenous 
host gene Gapdh, and fold change was calculated relative to WT B6 controls using the delta 
delta CT method [75]. Quantification of MNV-1 genome equivalents in host tissue was 
performed as previously described [14]. 
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Animal Infections. Mice were infected via oral gavage (o.g.) with 3.8 x 105 PFU MNV-1-NR or 
2.6x105 PFU MNV-CR3-NR in 100 l/mouse in a red light only room. Mice received 
intraperitoneal infection of 3.8 x 105 PFU MNV-1-NR in 100 l/mouse in a red light only room. 
Tissues were harvested at 9,  18, or 48 hours post infection (hpi) as previously described [76] 
with the following modifications: 2 cm of tissue was collected in pre-weighed tubes containing 
1.0 mm diameter zirconia/silica beads (BioSpec), flash frozen in an ethanol/dry ice bath, 
weighed, and stored at -80°C. Mice were infected via o.g. with 2x106 PFU of reovirus T1L. 
Tissues were harvested at 24 hpi and processed as described for MNV, with the modification that 
1 cm of tissue was collected.  
 
Plaque Assay. Homogenized samples were exposed to white light for 30 min to inactivate input 
virus. Light exposure reduced MNV-1-NR titers by 3 logs. The plaque assay was performed as 
previously described [77]. Samples without detectable replicated virus were assigned 10 PFU/ml 
as the lowest detectable unit. Data were normalized to the tissue weight and expressed as PFU 
per gram of tissue. The sensitivity threshold was determined for each organ by averaging the 
PFU/gram tissue of all samples without detectable viral titers. 
 
Antibiotic Treatment of PIgR KO Mice. Cefoperazone (MP biomedicals #199695) was diluted 
to [0.5g/L] in distilled water and kept protected from light using brown bottles and administered 
to conventionally housed pIgR KO mice via drinking water. Antibiotic treated, or regular 
distilled water as a control was changed every other day for 7 days. Mice were then infected with 
3.8 x 105 PFU MNV-1-NR via oral gavage and tissues and intestinal contents were collected at 9 
hpi under red light only conditions. Antibiotic treatment efficacy was assessed by collecting 
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intestinal contents from antibiotically treated and control pIgR KO mice at 18 hpi. Intestinal 
contents were allowed to pass through a 100-micron strainer by flushing with 10 mLs of cold 1x 
PBS. PBS was removed, and pass-through contents were collected after centrifugation (10,000 
rpm 5 min). Contents were weighed and resuspended in 500 l LB broth (Fisher Scientific) and 
equal weight of ileal contents was serially diluted in 500ul LB broth. 100 ul aliquots from each 
dilution was plated onto BHI plates and colonies >1.2mm were counted using an aCOLyte 
colony counter (Synbiosis) after overnight incubation at 37˚C. 
 
Intestinal Transit Assay. To measure intestinal transit time, mice were fasted for 18 h, gavaged 
orally with 100 ml 50 mg/ml Evans Blue solution in 1x PBS (Gibco) prepared with 1% 
methylcellulose and euthanized 15 min later. The small intestine was divided into fifths and each 
piece was minced in 1x PBS containing 0.1 M sodium hydroxide, 6 mM N-acetylcysteine, 
sonicated, and the absorbance at 565 nm determined as previously described [78]. 
 
Tissue Digestion/ Flow Cytometry. PP and small intestine lamina propria were dissected from 
naive PIgR KO and WT B6 mice and digested as previously described [49]. 2x106 cells were 
then used for flow cytometric analysis. Viable cells were identified (Invitrogen Live/Dead 
fixable Aqua Dead Cell stain Kit) and then stained for the following surface markers: CD45 
(diluted 1:200, clone 30-F11, AF700, Biolegend), I-A/I-E (diluted 1:50, clone M5/114.15.2, 
PE/Dazzle 594, Biolegend), CD19 (diluted 1:50, clone 6D5, PerCP/Cy5.5, Biolegend), CD11b 
(diluted 1:50, clone M1/70 APC/Cy7, Biolegend), CD64 (diluted 1:50, clone X54-5/7.1 FITC, 
Biolegend) CD11c (diluted 1:50, clone N418 PE/Cy7, Biolegend) CD103 (diluted 1:25, clone 
2EZ, APC, Biolegend), CX3CR1 (diluted 1:50, clone SA011F11, PE, Biolegend), CD8 (diluted 
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1:100, clone 53-6.7, APC-Cy7 Biolegend). All antibodies were diluted in FACS buffer; 5% fetal 
bovine serum (Hyclone) and 0.1% sodium azide (Sigma) in 1x PBS, for 30 min on ice. After 
surface staining, cells were fixed for 10 min on ice using Cytofix/Cytoperm (BD Biosciences), 
washed and fluorescence was analyzed with a BD LSR Fortessa. Data was analyzed using 
FlowJo software (BD Biosciences) using the gating strategy outlined in Table 3.1. 
 
Bacteroides thetaiotaomicron (B. theta) Monocolonization of Swiss Webster Mice.  
 
Germ-free Swiss Webster mice were either media treated or colonized via oral gavage with 
1x109 colony forming units of Bacteroides thetaiotaomicron (B. theta), for 2 weeks before 
infection with 3.8x105 MNV-1-NR via oral gavage. Small intestinal contents and the 
gastrointestinal tract was harvested at 9 hpi as described above. To assess colonization 
efficiency, DNA was isolated from intestinal contents using Promega Wizard genomic DNA 
purification kit Protocol 3.G. “Isolating Genomic DNA from Gram-Positive and Gram-Negative 
Bacteria” following the manufacturers protocols. The 16S DNA [79] was amplified in 5 ng total 
DNA using Taq polymerase (Invitrogen) and dNTPs (Invitrogen) and the following PCR 
reaction: 95˚C for 5 min, 95 ˚C for 30 sec, 50˚C for 30 sec, 72 ˚C for 1.5 min 72 ˚C for 5 min. 
PCR products were separated on a 2% agarose gel, stained with ethidium bromide (Fisher 
Scientific), and DNA was visualized via ultraviolet light. 
 
Statistical Analysis. Unless otherwise stated, data were analyzed using Mann Whitney U test 
with GraphPad Prism software version 7 (GraphPad Software, La Jolla, CA). *= P<0.05. **= 
P<0.01 ***= P<0.001. ****= P<0.0001. ns= not significant. 
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Chapter 4: Discussion & Future Directions 
 
4.1 Summary of Results 
Enteric virus infections, such as norovirus, cause significant morbidity and mortality worldwide. 
However, direct antiviral infection prevention strategies are limited. Herein, I investigated the 
role of the polymeric immunoglobulin receptor (pIgR) – secretory immunoglobulin (SIg) cycle 
and enteric bacteria during enteric virus infections. The classical innate immune functions of SIg 
(agglutination, immune exclusion, neutralization, and expulsion) were not required during 
control of acute murine norovirus (MNV) infection. Specifically, data in Figure 2.7D showed 
MNV epithelial binding was not altered, suggesting natural SIg-mediated agglutination and 
immune exclusion are not sufficient to limit MNV access to the epithelial barrier. SIg-mediated 
intraepithelial expulsion is also not sufficient to limit MNV epithelial crossing as Figure 2.7E 
shows no difference in MNV barrier crossing. Furthermore, data in Figure 2.2 showed reduced 
titers of MNV in intestinal tissues after the first and second round of viral replication suggesting 
that despite MNV binding to IgA and SC (data not shown) SIg is not mediating MNV 
neutralization in the lumen, or expulsion from the lamina propria. Instead, lack of pIgR resulted 
in increased IFN-ɣ levels in conventionally housed mice (see Figure 2.10A), This in turn 
contributed to reduced MNV titers (see Figure 2.12). Another enteric virus, reovirus, also 
showed decreased infection in pIgR KO mice (see Figure 2.4).  
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Investigation into the signals resulting in enhanced IFN-ɣ and iNOS stimulus in pIgR KO 
mice revealed altered intestinal microbial communities in pIgR KO mice (see Figure 3.1). When 
mice were rederived under germ-free conditions, IFN-ɣ and iNOS levels were equivalent 
between strains (see Figure 3.3A-B) as was MNV-1 viral replication (see Figure 3.4). Probing 
the role of intestinal bacteria on MNV infection, I found that bacteria alter MNV-1 and MNV-
CR3 gastrointestinal regionalization despite equivalent gastrointestinal motility (see Figure 
3.5G) and MNV target cell distribution (see Figure 3.7). Collectively, my data point to a model 
in which SIg-mediated microbial sensing promotes norovirus and reovirus infection (Figure 
4.1). These data provide the first evidence of the pro-viral role of natural SIg during enteric virus 
infections and provide another example of how intestinal bacterial communities indirectly 
influence MNV pathogenesis. These findings highlight the need to further study complex, trans-
kingdom interactions and their effects on the host. Below, I will discuss potential future studies 
into SIg and bacterial interactions with two enteric viruses; norovirus and reovirus. 
 
4.2 Determine Whether Natural Secretory Immunoglobulins and Polymeric 
Immunoglobulin Receptor Aid in Murine Norovirus Shedding 
There are several immune defense functions of SIg that may limit MNV access to the 
host interior and reduce infection, however the SIg:MNV interaction may also be beneficial for 
MNV. We hypothesized that MNV interaction with SIg may provide selective uptake of 
SIg:MNV complexes across the epithelial barrier by M cells. However, I was unable to detect  
any enhanced epithelial crossing of MNV in the presence of SIg. This suggests that SIg are 
neither helping nor hindering MNV to cross the epithelial barrier.  
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Figure 4.1: Model of natural secretory immunoglobulin enhancement of norovirus 
infection.  
Dimeric IgA are transcytosed across the mucosal epithelial barrier into the intestinal lumen 
via the polymeric immunoglobulin receptor (pIgR), forming secretory IgA (SIgA). In the 
lumen, SIgA binds to microbes via antigen-binding domains or carbohydrate residues. 
Specialized cells in the follicle-associated epithelium (FAE), called microfold (M) cells, 
transport SIgA-immune complexes and microbes into the PP lamina propria to be sampled 
by underlying dendritic cells (DC), which mediates immune responses. DC:immune 
complex sensing is tolerogenic and indirectly lowers levels of the anti-viral cytokine 
interferon gamma (IFNg), thus creating an environment which favors murine norovirus 
replication.  
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Dr. Mariam Gonzalez-Hernandez, a former graduate student of the Wobus lab, found that 
MNV-1 binds to dimeric IgA (dIgA) and secretory component (SC), the soluble form of pIgR 
(data not shown) [1]. Despite this interaction, no direct role for SIg in MNV infection could be 
determined. One possible unexplored outcome of the SIg:MNV interaction is that virus within 
the host interior can interact with newly synthesized dIgA and/or epithelial cell pIgR, and that 
the association would result in expulsion of the virus through the pIgR secretion pathway aiding 
in viral spread. Investigation into the role of pIgR and secretion of SIg in the excretion of MNV-
1, was unsuccessful as despite viral replication in multiple organs including the colon, replicated 
virus was undetectable in the feces of both pIgR KO or WT B6 mice at 9, 18 and 48 hpi (see 
Figure 2.2). Non-uniform MNV-1 shedding was only detected at 18 hpi (data not shown), 
however, infection with the persistent MNV-CR3 strain results in detectable viral shedding [2] 
allowing investigation into the role of SIg in MNV shedding. 
To assess the role of pIgR in MNV shedding I would infect mice orally with 
concentrated, high titer persistent MNV-CR3 to encourage robust infection and viral shedding. I 
would then assess shedding by sampling feces longitudinally at 0, 18, 24, 36, 48, and 60 hpi. 
Gastrointestinal tissues and feces would be harvested at 72 hpi and viral titers in tissues and feces 
would be determined via plaque assay. Virus detected in the feces at indicated time points would 
be compared to viral titers in the tissues at 72 hpi to determine percent viral shedding in pIgR 
KO compared to WT B6 mice. This comparison would allow us to control for any reduced 
infection seen in pIgR KO mice and more directly assess the role of SIg in MNV shedding. If 
SIg does enhance MNV shedding, further studies into SIg-mediated transmission of norovirus 
would be enlightening.  
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4.3 Determine Whether Natural Secretory Immunoglobulins Mediate Murine Norovirus 
Recombination 
SIg complexes allow for direct sampling by MNV susceptible antigen-presenting cells 
(APCs), which may facilitate MNV infection. When complexed with SIg, MNV-1 infection of 
the macrophage like cell line (RAW264.7) was not enhanced, although further experiments using 
primary APCs would be necessary to rule out enhanced MNV uptake in the presence of SIg. 
Norovirus binding to multivalent SIg complexes may also promote co-infections of APCs, which 
in turn can increase viral fitness via complementation or recombination (e.g., [3-5]). However, 
additional work is needed to test these hypotheses. 
 
4.4 Determine Whether Interferon-ɣ Limits Acute Reovirus Infection in Polymeric 
Immunoglobulin Receptor KO Mice 
My data showed reduced reovirus infection of pIgR KO mice (see Figure 2.4), but I did 
not investigate the mechanism of reduced infection. Similar to MNV, reovirus replication is 
sensitive to IFN-ɣ [6, 7]. Thus, I hypothesize that enhanced levels of this cytokine may also be 
directly responsible for reduced viral loads seen in pIgR KO mice compared to WT B6 controls. 
To determine if the enhanced baseline IFN-ɣ levels seen in pIgR KO mice account for reduced 
reovirus replication in pIgR KO mice, I would repeat the experiments in Figure 2.12 described 
for MNV with reovirus T1L. Briefly, I would treat pIgR KO mice with 500 g isotype control or 
IFN-ɣ neutralizing antibody 18 hours prior to reovirus infection. Additionally, control or IFN-ɣ 
treated B6 mice would be infected with reovirus 24 hours after treatment. After 24 hours, tissues 
would be harvested, and viral titers would be assessed via plaque assay. I hypothesize that 
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reovirus viral loads would be reduced in the presence of enhanced IFN-ɣ (isotype treated pIgR 
KO and IFN-ɣ treated B6) regardless of mouse genetic background.  
It would also be interesting to investigate if the reduction of reovirus infection in pIgR 
KO mice is due to immune cell sensing of the intestinal microbiota as is seen in norovirus 
infection. To this aim, germ-free pIgR KO and WT B6 would be infected with reovirus and viral 
replication would be assessed 24 hpi via plaque assay. Concurrent infection of conventionally 
housed mice would provide insight into the role of intestinal microbiota in the facilitation of 
reovirus infection. Successful completion of these experiments would provide further evidence 
of the antiviral role of IFN-ɣ in enteric viral infection and may provide potential avenues for 
treatment in other double-stranded RNA viral infections such as rotavirus or blue tongue virus. 
 
4.5 Determine Whether Natural Secretory Immunoglobulins Alter M Cell Patterning 
Within Peyer's Patches  
M cells rely on immune cues for development, which could be altered in the absence of 
SIg. To assess M cells levels in the absence of SIg, I analyzed M cell-related transcripts (Spi-B 
and GP2) and found no differences between strains (see Figure 2.6B). This data suggests similar 
levels of functional M cells, which is further supported by the finding that MNV-1, which 
utilizes M cells [8, 9], crosses the epithelial barrier similarly between strains (see Figure 2.7). 
However, analysis of the distribution of M cells within the Peyer’s patch (PP) via 
immunofluorescence would be necessary to make a final conclusion regarding M cell levels in 
the absence of SIg. The absence of SIg, and altered microbiota (see Figure 3.1), might also result 
in other intestinal abnormalities. To fully investigate the role of SIg in shaping the intestinal 
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tissue, naïve intestines would need to be processed, sectioned, and stained for specialized cells in 
the epithelial barrier such as enteroendocrine cells, Paneth cells, and tuft cells, the latter of which 
are known MNV target cells [10]. M cells are attractive therapeutic targets for drug delivery in 
mucosal diseases [11, 12], and enhancing the proportion of M cells within the PP may aid in 
uptake of therapeutics.  
 
4.6 Determine the Molecular Basis of Murine Norovirus Binding to Natural Secretory 
Immunoglobulins  
MNV has been shown to bind to N- and O-linked carbohydrate residues on host cells [13] 
and these same glycosylations are also found on pIgA, SIgA, and SC [14-19]. Therefore, we 
hypothesize that MNV capsid protein P-domain binding to SIg is likely mediated by N- and O-
linked glycosylations. However, these carbohydrate residues are necessary for proper protein 
folding, making assessment of the interaction by removal of these residues difficult. One 
potential approach to determine if MNV is binding to N- and O-linked glycosylations present on 
SIg,is to perform a competition experiment. Pre-incubation of MNV with N- and O-linked 
carbohydrate residues should inhibit MNV:SIg interactions. If MNV P-domain does mediate SIg 
binding via N- and O-linked glycosylations, future assessment of MNV P-domain binding to 
other immunoglobulins such as secretory IgM, which is also present in the intestinal lumen and 
lamina propria, would be enlightening. Human norovirus (HuNoV) also interacts with 
carbohydrate structures, including histo-blood group antigens [20-24], as well as fucose and 
sialic acid carbohydrate residues [25]. Fucosylated and sialydated carbohydrate residues are 
present on human SIgA [16, 26], therefore it is possible that HuNoV may also interact with SIg. 
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Using a capture ELISA to determine binding, HuNoV virus-like particles could be screened 
against human immunoglobulins and secretory component. I hypothesize that HuNoV is capable 
of interacting with human immunoglobulins and secretory component. These findings would 
allow for a greater understanding of the complex luminal environment and provide potential 
therapeutic and prevention avenues. 
 
4.7 Determine Whether Natural Secretory Immunoglobulins Inhibit Murine Norovirus 
Mucosal Barrier Crossing 
A major caveat to the intestinal loop assays is the injection of 100 l of fluid into a small 
(~2 cm) closed off section of the intestine. This mass injection of fluid may wash away SIg 
containing mucus from the epithelial surface, thereby removing any ability for the mucus bound 
SIg to exert its effector functions. MNV pre-incubation with SIg prior to injection into the 
intestinal loop failed to alter MNV binding to the epithelium or MNV epithelial crossing (see 
Figure 2.7D-E). However, SIg may mediate its innate effector functions to prevent virus 
crossing through the mucus layer, and removal of the mucus layer may make SIg innate immune 
functions such as immune exclusion ineffective. 
To assess the role of SIg in MNV crossing without disrupting mucosal barriers, MNV-1 
would be administered to pIgR KO or WT B6 mice via oral gavage and intestinal tissues and 
Peyer’s patches would be harvested shortly after viral administration. Based on intestinal transit 
data, traces of a one percent methylcellulose solution can already be detected in the distal small 
intestine 15 minutes after administration (see Figure 2.10G). M cells have been shown to 
transcytose particles in as few as 15 minutes [8], and given that the virus inoculum is 
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considerably less viscous than one percent methylcellulose, I hypothesize it would move through 
the gastrointestinal system at an accelerated rate. Therefore, I would harvest tissues at 30 minutes 
after administration of virus. After harvest of intestinal contents, Peyer’s patches, and remaining 
intestinal tissue, samples would be processed to assess viral loads via RT-qPCR. The epithelial 
barrier would be digested from the lamina propria using DTT as to assess binding to and crossing 
of the epithelial barrier.  
Given that MNV uses M cells to aid in barrier crossing [8, 9] and MNV target cells are 
concentrated within the follicle associated epithelium [12], it is no surprise that MNV-1 
replication has been shown to be concentrated in Peyer’s patches [27]. I hypothesize that MNV 
primarily crosses the intestinal epithelial barrier at lymphoid structures, and collection and 
assessment of non-lymphoid tissue as well as Peyer’s patches from WT B6 mice would allow me 
to determine the proportion of virus crossing the barrier at lymphoid structures and pIgR KO 
tissues would allow assessment of the contribution of SIg in physiologic MNV crossing.   
 
4.8 Determine Whether Natural Secretory Immunoglobulins Alter Small Intestinal 
Immune Subsets 
  At the time of characterization of MNV target cells in pIgR KO and WT B6 mice (see 
Figure 2.8), T cells [27] and tuft cells [10] were not known MNV target cells. No one to date has 
investigated tuft cell levels in pIgR KO compared to control mice. Thus, an investigation would 
be warranted to determine whether the lack of pIgR affects tuft cell levels. Furthermore, previous 
studies have shown that T cells expand to similar levels in response to pathogens in pIgR KO 
compared to control mice [28], and that pIgR KO mice have enhanced numbers of intraepithelial 
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lymphocytes (IELs) [29, 30]. This data suggests naïve T cells are enhanced in pIgR KO mice, 
but more direct analysis of T cell populations in naïve animals is needed.  
Given that there are enhanced numbers of APCs and enhanced inflammatory molecules 
IFN-ɣ and iNOS, it is possible that MNV target cells in pIgR KO mice are activated to a greater 
degree [31]. Interestingly, despite enhanced IFN-ɣ levels, phenotypic analysis of mononuclear 
phagocytes (macrophages and dendritic cells) in the intestines of pIgR KO and control mice 
revealed no major differences (see Figure 2.9). Further characterization and functional analysis 
of intestinal immune cells should be carried out to determine the role of SIg in immune cell 
programming. Previous investigations into the role of SIg in immune cell activation and 
programming suggest that SIg sampling initiates non-inflammatory activation of dendritic cells 
and results in alterations in intestinal immune cell subsets, specifically enhancement of T 
regulatory cells [32-36]. Therefore, our finding that mononuclear phagocyte subsets are not 
altered in the absence of SIg would suggest that other unknown factors may aid in establishment 
of mucosal tolerance. 
 
4.9 Determine Whether Interaction of Murine Norovirus with Natural Secretory 
Immunoglobulin Complexes Skews Viral Immunity to Promote Infection 
To address immunomodulatory functions of both SIg and MNV-1, I would treat isolated 
intestinal immune cells with MNV-1, natural, non-MNV specific, SIg, and both MNV-1 and 
natural SIg together for 0, 18, 24, or 48 hpi. Examination of immune cell responses (cytokines, 
pattern recognition receptors, activation markers, etc.) via RT-qPCR and flow cytometry would 
allow for further investigation into the tolerogenic properties of SIg, as well as innate immune 
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responses to MNV. To address the role of bacteria in MNV-mediated immunomodulation in a 
more comprehensive manner, a gene array of common host cytokine responses would be 
analyzed in ileal Peyer’s patches of infected germ-free versus conventional WT B6 mice as 
compared to naïve controls. In addition to assessment of host cytokine responses to MNV 
infection, analysis of pIgR expression changes would be interesting given other pathogens 
modulate pIgR expression [37].  
In addition to SIg-mediated immune modulation, intestinal bacteria can also influence 
intestinal immunity. In MNV-infected conventional WT B6 mice, transcript levels of IFN- and 
TNF- were reduced compared to naïve conventional controls (see Figure 2.10C-D), and in 
infected conventional pIgR KO mice IFN-ɣ transcript levels were reduced (see Figure 2.10A). 
Interestingly, the immunomodulatory functions of MNV seem to be dependent on enteric 
microbiota as transcript reductions are not observed in germ-free WT B6 or pIgR KO animals 
(see Figure 3.3A & 3.3C-D). MNV-mediated reduction of IFN-ɣ in conventional mice was not 
recapitulated in germ-free mice, where IFN-ɣ protein increased after infection of PIgR KO vs 
naive controls (see Figure 3.3G). Future work is required to test whether interaction of enteric 
viruses with SIg:bacterial complexes could skew the inflammatory viral immune response 
promoting tolerogenic responses and intestinal homeostasis. Such a response may account for the 
weak inflammatory response and poor lasting immunity observed in norovirus infections [38].  
 
4.10 Determine Whether Small Intestinal Macrophages are Resistant to Murine Norovirus 
Infection 
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 Immune cells stimulated with IFN-ɣ have been shown to be resistant to MNV-1 viral 
replication in vitro [39-41]. Therefore, I sought to determine if in vivo IFN-ɣ levels influence ex 
vivo infectivity of intestinal immune cells from pIgR KO and WT B6 animals. To that end, I 
isolated intestinal immune cells from the villous and PP lamina propria and infected them with 
MNV-1. Unfortunately, I was not able to detect productive MNV-1 infection in ex vivo small 
intestinal cells from either mouse strain (see Figure 2.11). In addition, my investigation into 
MNV-1 in vivo target cells from infected ilea and PP’s of highly MNV susceptible STAT1-/- 
mice [42] using a flow cytometry-based in situ hybridization assay to detect viral RNA were 
unsuccessful (n=3 experiments, 4 infected, 3 mock; data not shown). While these findings are 
preliminary, it appears as though lamina propria cells isolated from the small intestine are 
refractory to ex vivo MNV-1 infection regardless of mouse genotype. Since MNV successfully 
infects cells in vivo, I would want to confirm these ex vivo findings.  
It is unclear how long intestinal immune cells survive ex vivo, therefore phenotypic and 
viability analysis of isolated cell types should be performed via flow cytometry to assure viable 
MNV target cells are present in the culture. In addition, although I saw no enhancement of 
genome copies at 9 hpi that may be too soon to detect replication (see Figure 2.11C-E). In the 
future, MNV viral genome copies should be assessed at 24 hpi to allow for detection of enhanced 
genome copies, while minimizing the amount of ex vivo cell death. If productive replication of 
immune cells from the small intestine can be achieved ex vivo, one can begin to ask questions 
regarding their immune responses to MNV as antigen-presenting cells in the presence and 
absence of SIg, as well as assess their susceptibility to MNV infection. Additionally, cultivation 
of an ex vivo system for assessment of MNV infection would allow for more physiologically 
relevant assessments of host responses to norovirus infection. 
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4.11 Determine Whether MNV-CR3 is Sensitive to Interferon-ɣ Mediated Control of Viral 
Replication 
Interestingly, MNV-CR3 infection was not altered in pIgR KO mice, despite enhanced 
IFN-ɣ levels in target organs (see Figure 2.3D & Figure 2.10G). To date, all published studies 
regarding MNV susceptibility to IFN-ɣ use the MNV-1 strain only, therefore it would be 
interesting to determine if MNV-CR3 is also susceptible to IFN-ɣ mediated control of viral 
replication. To determine if IFN-ɣ alters MNV-CR3 infection, I would infect the macrophage-
like cell line (RAW264.7), as well as primary bone marrow derived macrophages with MNV-
CR3 in the presence of increasing concentrations (0 to 1000 units/ml) of murine IFN-ɣ at a 
multiplicity of infection (MOI) of 0.05 and 5 and viral titers would be assessed at 0, 18, 24 and 
48 hours post infection (hpi) via plaque assay.  
Given that MNV-CR3 also utilizes replication complexes, and IFN- ɣ mediates disruption 
of these complexes, it would be very interesting to find that it was insensitive to IFN-ɣ mediated 
replication complexes disruption. To determine if IFN-ɣ mediates disruption of MNV-CR3 
replication complex, increases in the IFN-ɣ-inducible immunity-related GTPase IRGA6 would 
also be assessed [39]. Several other positive-sense, single-stranded RNA viruses have been 
shown to be controlled by IFN-ɣ during the replication phase [43-45]. Identification of IFN-ɣ-
mediated disruption of the viral replication complex in MNV-CR3 and other positive-sense, 
single-stranded RNA virus infections would enhance our understanding of IFN-ɣ-mediated 
antiviral immunity. 
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4.12 Determine Which Intestinal Microbial Communities Enhance Interferon-ɣ in 
Polymeric Immunoglobulin Receptor KO Mice 
The finding that intestinal microbial communities are altered throughout the intestinal 
tract in the absence of SIg (see Figure 3.1A-F) is hardly surprising given the overwhelming 
evidence regarding the role of SIg in shaping intestinal microbial communities [15, 18, 33, 35-
37, 46]. To determine which bacteria induce IFN-ɣ in pIgR KO mice, I would select bacterial 
species from our 16S rRNA analysis found in the intestinal lumen of pIgR KO mice known to 
induce inflammatory immune responses. For example, Erysipelotrichaceae species were found 
to be increased in the intestinal lumen and mucosal tissues of pIgR KO mice versus WT B6 
controls (see Figure 3.1) and are highly immunogenic [47]. Monocolonization of germ-free pIgR 
KO mice with Erysipelotrichaceae species and subsequent IFN-ɣ transcript and protein analysis 
in intestinal tissues would determine their immunogenicity in the absence of SIg. Aberrant 
inflammation caused by alterations in microbial communities can result in irritable bowel 
syndrome, Crohn’s disease and ulcerative colitis and the intestinal microbiota have been linked 
to many seemingly unrelated maladies including depression, obesity and autism [48-52]. 
Identification of specific bacterial species that enhance intestinal inflammation would allow for 
avenues of treatment of the above maladies through modulation of harmful bacterial species in 
disease states. 
 
4.13 Determine the Mechanism of Bacterially-Mediated MNV-1 & MNV-CR3 
Gastrointestinal Regionalization 
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4.13A Determine if Loss of Mucosal Barrier Integrity Results in Altered Murine Norovirus 
Gastrointestinal Regionalization 
MNV infection in the absence of the microbiota results in altered intestinal 
regionalization of MNV infection with more virus produced in the proximal versus distal small 
intestine in the absence of the microbiota (see Figures 3.5 & 3.6). The intestinal mucus layer has 
been shown to be more permeable in germ-free housed mice than in conventionally housed 
controls [50, 53]. Perhaps the reduction in mucus facilitates enhanced access of MNV to the first 
intestinal epithelial surface it encounters, the duodenum. Additionally, intestinal epithelial barrier 
integrity could be compromised in mice housed under germ-free conditions [54], resulting in 
leakier intestines and greater absorption of MNV in the proximal small intestine. These factors 
may explain the altered intestinal distribution of MNV in the absence of the intestinal microbiota 
(see Figure 3.5) and are potential avenues of further exploration.  
To determine if our germ-free mice have altered intestinal permeability, small and large 
intestines from naïve germ-free and conventional WT B6 mice would be harvested and 
processed for histological examination and immunofluorescence imaging of the mucus layer and 
tight junctional proteins. Permeability of intestines would be directly measured using penetration 
of FITC-dextran into the intestinal lamina propria of conventional and germ-free WT B6 mice 
[55]. To directly test MNV permeability across the intestinal barrier, I would inoculate 
conventional and germ-free WT B6 mice with MNV-1 and harvest intestines less than one hour 
after viral administration. MNV genome copies in the lamina propria of the duodenum, jejunum, 
and ileum would be assessed via RT-qPCR allowing us to determine if enhanced access to the 
lamina propria of the proximal small intestine in germ-free mice can account for the altered viral 
distribution compared to conventional controls.  
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Loss of barrier integrity in germ-free mice may also affect viral shedding. If we 
determine germ-free mice have altered intestinal barrier integrity, conventional and germ free 
WT B6 mice would be infected with high titer MNV-CR3 as this MNV strain has been shown to 
cause viral shedding [56]. Feces would be collected daily for one week and MNV genome copies 
would be assessed via RT-qPCR to determine the role of bacteria in MNV viral shedding. 
Determination of the mechanism of bacterially-mediated norovirus gastrointestinal 
regionalization would provide insights into the complex role of intestinal bacteria during MNV 
infection, which may also extend to HuNoV and other enteric viral infections. 
 
4.13B Determine Whether Bacterial Colonization of Germ-Free Mice Alter Murine 
Norovirus Gastrointestinal Regionalization 
Discovery of specific bacterial species capable of correcting MNV gastrointestinal 
regionalization in germ-free animals to that of conventional mice would allow for mechanistic 
studies regarding MNV intestinal distribution. My pilot studies tested Bacteroides 
thetaiotaomicron (B. theta) as a modulator of MNV infection (see Figure 3.9A). Since the B. 
theta colonization was not robust enough in germ-free animals more experiments are needed to 
determine whether the intestinal distribution of MNV infection is modulated by this bacterial 
species. Longer colonization, and multiple inoculations of B. theta may enhance colonization and 
allow for a more accurate examination of the role of B. theta in MNV infection. It is likely 
however that several species of bacteria are capable of interacting with MNV and indirectly or 
directly modulating MNV infection. Therefore, it may be necessary to inoculate germ-free mice 
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with a cocktail of several bacterial species to see robust colonization and a reversal of the germ-
free phenotype. 
 In addition to identifying specific bacterial species that modulate MNV regionalization 
of infection, another unresolved question is the molecular determinant of MNV binding on the 
bacteria. To determine what bacterial factor(s) mediate MNV binding to bacteria, we would 
assess bacterial characteristics such as LPS, Flagella, HBGA, sialic acids, and SIg binding. This 
analysis would offer the first evidence of MNV:bacterial interactions and may provide clues 
regarding the mechanism of this interaction. Direct MNV binding of bacterial factors of interest 
would be demonstrated using ELISA. To determine the role of specific bacterial factor(s) in 
MNV infection, we would engineer bacteria deficient in the protein(s) of interest in collaboration 
with Dr. Nicole Koropatkin’s lab. Reconstitution of germ-free mice with WT or deficient 
bacteria prior to MNV infection and MNV viral loads would be assessed via plaque assay. If the 
bacterial factor is important for MNV infection, I would likely see reduced viral infection in 
mice colonized with bacterial factor-deficient versus WT bacteria. If differences in viral loads 
were detected, analysis of in vivo MNV:bacterial interactions as well as viral crossing of 
intestinal barriers would be assessed to determine the function of the bacterial factor of interest 
in MNV infection. It is conceivable that through these studies we could discover specific 
bacterial species that modulate norovirus infection, providing potential avenues for norovirus 
treatment. 
 
4.14 Concluding Remarks 
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 No organism exists in isolation. Likewise, people are teeming with bacteria and other 
microbes, and it is highly likely that unrecognized trans-kingdom interactions exist within the 
human gastrointestinal tract. These interactions may have unrecognized effects on both host and 
pathogen. Studying pathogen:pathogen and pathogen:commensal interactions within the host 
allows for a more complex and thorough understanding of infection. Investigation of SIg-
mediated modulation of immunity in the context of these trans-kingdom interactions are severely 
limited, or entirely lacking. Completion of the proposed experiments would allow for a broader 
understanding of the complex interactions of secretory immunoglobulins, norovirus, and bacteria 
and may provide avenues of exploration for other enteric viral infections as well as norovirus 
treatment options.  
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